Title：A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
Authors：Foster, S L; Woolsey, C; Borisevich, V; Agans, K N; Prasad, A N; etc.
Date Display: 2022-03-22
文献主题：药物与疫苗研发 (共500篇，更新至2022年3月16日)
Title：Specialized interferon action in COVID-19
Authors：Galbraith, M D; Kinning, K T; Sullivan, K D; Araya, P; Smith, K P; etc.
Date Display: 2022-03-15
Authors：Galbraith, M D; Kinning, K T; Sullivan, K D; Araya, P; Smith, K P; etc.
Date Display: 2022-03-15
Title：Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
Authors：Shan, S; Luo, S; Yang, Z; Hong, J; Su, Y; Ding, F; Fu, L; Li, C; Chen, P; etc.
Date Display: 2022-03-15
Authors：Shan, S; Luo, S; Yang, Z; Hong, J; Su, Y; Ding, F; Fu, L; Li, C; Chen, P; etc.
Date Display: 2022-03-15
Title：Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Authors：Gupta, A; Gonzalez-Rojas, Y; Juarez, E; Crespo, Casal M; Moya, J; etc.
Date Display: 2022-03-14
Authors：Gupta, A; Gonzalez-Rojas, Y; Juarez, E; Crespo, Casal M; Moya, J; etc.
Date Display: 2022-03-14
Title：Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
Authors：Prunas, O; Warren, J L; Crawford, F W; Gazit, S; Patalon, T; Weinberger, D M; Pitzer, V E
Date Display: 2022-03-11
Authors：Prunas, O; Warren, J L; Crawford, F W; Gazit, S; Patalon, T; Weinberger, D M; Pitzer, V E
Date Display: 2022-03-11
Title：COVID-19 vaccination: The road ahead
Authors：Altmann, D M; Boyton, R J
Date Display: 2022-03-11
Authors：Altmann, D M; Boyton, R J
Date Display: 2022-03-11
Title：Indirect protection of children from SARS-CoV-2 infection through parental vaccination
Authors：Hayek, S; Shaham, G; Ben-Shlomo, Y; Kepten, E; Dagan, N; Nevo, D; etc.
Date Display: 2022-03-11
Authors：Hayek, S; Shaham, G; Ben-Shlomo, Y; Kepten, E; Dagan, N; Nevo, D; etc.
Date Display: 2022-03-11
Title：Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina
Authors：Lin, D Y; Gu, Y; Wheeler, B; Young, H; Holloway, S; Sunny, S K; etc.
Date Display: 2022-03-10
Authors：Lin, D Y; Gu, Y; Wheeler, B; Young, H; Holloway, S; Sunny, S K; etc.
Date Display: 2022-03-10
Title：Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
Authors：Sablerolles, RSG; Rietdijk, WJR; Goorhuis, A; Postma, D F; Visser, L G; etc.
Date Display: 2022-03-10
Authors：Sablerolles, RSG; Rietdijk, WJR; Goorhuis, A; Postma, D F; Visser, L G; etc.
Date Display: 2022-03-10
Title：Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
Authors：Abu-Raddad, L J; Chemaitelly, H; Ayoub, H H; AlMukdad, S; etc.
Date Display: 2022-03-09
Authors：Abu-Raddad, L J; Chemaitelly, H; Ayoub, H H; AlMukdad, S; etc.
Date Display: 2022-03-09
Title：Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Authors：Lauring, A S; Tenforde, M W; Chappell, J D; Gaglani, M; Ginde, A A; etc.
Date Display: 2022-03-09
Authors：Lauring, A S; Tenforde, M W; Chappell, J D; Gaglani, M; Ginde, A A; etc.
Date Display: 2022-03-09
Title：KIR(+)CD8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19
Authors：Li, J; Zaslavsky, M; Su, Y; Guo, J; Sikora, M J; van Unen, V; Christophersen, A; etc.
Date Display: 2022-03-08
Authors：Li, J; Zaslavsky, M; Su, Y; Guo, J; Sikora, M J; van Unen, V; Christophersen, A; etc.
Date Display: 2022-03-08
Title：Whole genome sequencing reveals host factors underlying critical Covid-19
Authors：Kousathanas, A; Pairo-Castineira, E; Rawlik, K; Stuckey, A; etc.
Date Display: 2022-03-07
Authors：Kousathanas, A; Pairo-Castineira, E; Rawlik, K; Stuckey, A; etc.
Date Display: 2022-03-07
Title：Prioritise research on vaccines for pregnant and breastfeeding women
Authors：Manca, T; Baylis, F; Munoz, F M; Top, K A
Date Display: 2022-03-05
Authors：Manca, T; Baylis, F; Munoz, F M; Top, K A
Date Display: 2022-03-05
Title：Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Authors：Feikin, D R; Higdon, M M; Abu-Raddad, L J; Andrews, N; Araos, R; etc.
Date Display: 2022-03-05
Authors：Feikin, D R; Higdon, M M; Abu-Raddad, L J; Andrews, N; Araos, R; etc.
Date Display: 2022-03-05
Title：Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination
Authors：Kaku, C I; Champney, E R; Normark, J; Garcia, M; Johnson, C E; Ahlm, C; etc.
Date Display: 2022-03-04
Authors：Kaku, C I; Champney, E R; Normark, J; Garcia, M; Johnson, C E; Ahlm, C; etc.
Date Display: 2022-03-04
Title：SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Authors：Walls, A C; Sprouse, K R; Bowen, J E; Joshi, A; Franko, N; Navarro, M J; etc.
Date Display: 2022-03-03
Authors：Walls, A C; Sprouse, K R; Bowen, J E; Joshi, A; Franko, N; Navarro, M J; etc.
Date Display: 2022-03-03
Title：SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
Authors：Tarke, A; Coelho, C H; Zhang, Z; Dan, J M; Yu, E D; Methot, N; etc.
Date Display: 2022-03-03
Authors：Tarke, A; Coelho, C H; Zhang, Z; Dan, J M; Yu, E D; Methot, N; etc.
Date Display: 2022-03-03
Title：Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Authors：Cui, Z; Liu, P; Wang, N; Wang, L; Fan, K; Zhu, Q; Wang, K; Chen, R; etc.
Date Display: 2022-03-03
Authors：Cui, Z; Liu, P; Wang, N; Wang, L; Fan, K; Zhu, Q; Wang, K; Chen, R; etc.
Date Display: 2022-03-03
Title：Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
Authors：Afkhami, S; D'Agostino, M R; Zhang, A; Stacey, H D; Marzok, A; etc.
Date Display: 2022-03-03
Authors：Afkhami, S; D'Agostino, M R; Zhang, A; Stacey, H D; Marzok, A; etc.
Date Display: 2022-03-03
Title：Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Authors：Andrews, N; Stowe, J; Kirsebom, F; Toffa, S; Rickeard, T; Gallagher, E; etc.
Date Display: 2022-03-02
Authors：Andrews, N; Stowe, J; Kirsebom, F; Toffa, S; Rickeard, T; Gallagher, E; etc.
Date Display: 2022-03-02
Title：Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Authors：Lee, ARYB; Wong, S Y; Chai, LYA; Lee, S C; Lee, M X; Muthiah, M D; etc.
Date Display: 2022-03-02
Authors：Lee, ARYB; Wong, S Y; Chai, LYA; Lee, S C; Lee, M X; Muthiah, M D; etc.
Date Display: 2022-03-02
Title：Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion
Authors：Vora, S M; Fontana, P; Mao, T; Leger, V; Zhang, Y; Fu, T M; Lieberman, J; etc.
Date Display: 2022-03-01
Authors：Vora, S M; Fontana, P; Mao, T; Leger, V; Zhang, Y; Fu, T M; Lieberman, J; etc.
Date Display: 2022-03-01
Title：Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
Authors：Moeller, N H; Shi, K; Demir, ?; Belica, C; Banerjee, S; Yin, L; Durfee, C; etc.
Date Display: 2022-03-01
Authors：Moeller, N H; Shi, K; Demir, ?; Belica, C; Banerjee, S; Yin, L; Durfee, C; etc.
Date Display: 2022-03-01
Title：Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
Authors：Wu, C Y; Cheng, C W; Kung, C C; Liao, K S; Jan, J T; Ma, C; Wong, C H
Date Display: 2022-03-01
Authors：Wu, C Y; Cheng, C W; Kung, C C; Liao, K S; Jan, J T; Ma, C; Wong, C H
Date Display: 2022-03-01
Title：The cGAS-STING pathway drives type I IFN immunopathology in COVID-19
Authors：Domizio, J D; Gulen, M F; Saidoune, F; Thacker, V V; Yatim, A; etc.
Date Display: 2022-03-01
Authors：Domizio, J D; Gulen, M F; Saidoune, F; Thacker, V V; Yatim, A; etc.
Date Display: 2022-03-01
Title：Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
Authors：Nordstr?m, P; Ballin, M; Nordstr?m, A
Date Display: 2022-02-26
Authors：Nordstr?m, P; Ballin, M; Nordstr?m, A
Date Display: 2022-02-26
Title：Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Authors：McCallum, M; Czudnochowski, N; Rosen, L E; Zepeda, S K; Bowen, J E; etc.
Date Display: 2022-02-25
Authors：McCallum, M; Czudnochowski, N; Rosen, L E; Zepeda, S K; Bowen, J E; etc.
Date Display: 2022-02-25
Title：Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
Authors：Eyre, D W; Taylor, D; Purver, M; Chapman, D; Fowler, T; Pouwels, K B; etc.
Date Display: 2022-02-24
Authors：Eyre, D W; Taylor, D; Purver, M; Chapman, D; Fowler, T; Pouwels, K B; etc.
Date Display: 2022-02-24
Title：Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
Authors：Madhi, S A; Kwatra, G; Myers, J E; Jassat, W; Dhar, N; Mukendi, C K; etc.
Date Display: 2022-02-23
Authors：Madhi, S A; Kwatra, G; Myers, J E; Jassat, W; Dhar, N; Mukendi, C K; etc.
Date Display: 2022-02-23
Title：Testing fractional doses of COVID-19 vaccines
Authors：Więcek, W; Ahuja, A; Chaudhuri, E; Kremer, M; Simoes, Gomes A; etc.
Date Display: 2022-02-22
Authors：Więcek, W; Ahuja, A; Chaudhuri, E; Kremer, M; Simoes, Gomes A; etc.
Date Display: 2022-02-22
Title：Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
Authors：Schuhenn, J; Meister, T L; Todt, D; Bracht, T; Schork, K; Billaud, J N; etc.
Date Display: 2022-02-22
Authors：Schuhenn, J; Meister, T L; Todt, D; Bracht, T; Schork, K; Billaud, J N; etc.
Date Display: 2022-02-22
Title：Targeting ectromelia virus and TNF/NF-κB or STAT3 signaling for effective treatment of viral pneumonia
Authors：Pandey, P; Al, Rumaih Z; Kels, MJT; Ng, E; Kc, R; Chaudhri, G; Karupiah, G
Date Display: 2022-02-22
Authors：Pandey, P; Al, Rumaih Z; Kels, MJT; Ng, E; Kc, R; Chaudhri, G; Karupiah, G
Date Display: 2022-02-22
Title：SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex
Authors：Mannar, D; Saville, J W; Zhu, X; Srivastava, S S; Berezuk, A M; etc.
Date Display: 2022-02-18
Authors：Mannar, D; Saville, J W; Zhu, X; Srivastava, S S; Berezuk, A M; etc.
Date Display: 2022-02-18
Title：An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity
Authors：Borriello, F; Poli, V; Shrock, E; Spreafico, R; Liu, X; Pishesha, N; etc.
Date Display: 2022-02-17
Authors：Borriello, F; Poli, V; Shrock, E; Spreafico, R; Liu, X; Pishesha, N; etc.
Date Display: 2022-02-17
Title：SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
Authors：Mudd, P A; Minervina, A A; Pogorelyy, M V; Turner, J S; Kim, W; etc.
Date Display: 2022-02-17
Authors：Mudd, P A; Minervina, A A; Pogorelyy, M V; Turner, J S; Kim, W; etc.
Date Display: 2022-02-17
Title：Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Authors：Han, P; Li, L; Liu, S; Wang, Q; Zhang, D; Xu, Z; Han, P; Li, X; Peng, Q; etc.
Date Display: 2022-02-17
Authors：Han, P; Li, L; Liu, S; Wang, Q; Zhang, D; Xu, Z; Han, P; Li, X; Peng, Q; etc.
Date Display: 2022-02-17
Title：Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19
Authors：Hammerman, A; Sergienko, R; Friger, M; Beckenstein, T; Peretz, A; etc.
Date Display: 2022-02-16
Authors：Hammerman, A; Sergienko, R; Friger, M; Beckenstein, T; Peretz, A; etc.
Date Display: 2022-02-16
Title：Germinal centre-driven maturation of B cell response to mRNA vaccination
Authors：Kim, W; Zhou, J Q; Horvath, S C; Schmitz, A J; Sturtz, A J; Lei, T; etc.
Date Display: 2022-02-15
Authors：Kim, W; Zhou, J Q; Horvath, S C; Schmitz, A J; Sturtz, A J; Lei, T; etc.
Date Display: 2022-02-15
Title：Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Authors：Accorsi, E K; Britton, A; Fleming-Dutra, K E; Smith, Z R; Shang, N; etc.
Date Display: 2022-02-15
Authors：Accorsi, E K; Britton, A; Fleming-Dutra, K E; Smith, Z R; Shang, N; etc.
Date Display: 2022-02-15
Title：Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance
Authors：Britton, A; Fleming-Dutra, K E; Shang, N; Smith, Z R; Dorji, T; etc.
Date Display: 2022-02-14
Authors：Britton, A; Fleming-Dutra, K E; Shang, N; Smith, Z R; Dorji, T; etc.
Date Display: 2022-02-14
Title：Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera
Authors：Muik, A; Lui, B G; Wallisch, A K; Bacher, M; Mühl, J; Reinholz, J; etc.
Date Display: 2022-02-11
Authors：Muik, A; Lui, B G; Wallisch, A K; Bacher, M; Mühl, J; Reinholz, J; etc.
Date Display: 2022-02-11
Title：Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study
Authors：Fabiani, M; Puopolo, M; Morciano, C; Spuri, M; Spila, Alegiani S; etc.
Date Display: 2022-02-10
Authors：Fabiani, M; Puopolo, M; Morciano, C; Spuri, M; Spila, Alegiani S; etc.
Date Display: 2022-02-10
Title：Rapid increase in Omicron infections in England during December 2021: REACT-1 study
Authors：Elliott, P; Bodinier, B; Eales, O; Wang, H; Haw, D; Elliott, J; Whitaker, M; etc.
Date Display: 2022-02-08
Authors：Elliott, P; Bodinier, B; Eales, O; Wang, H; Haw, D; Elliott, J; Whitaker, M; etc.
Date Display: 2022-02-08
Title：Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells
Authors：Amraei, R; Xia, C; Olejnik, J; White, M R; Napoleon, M A; Lotfollahzadeh, S; etc.
Date Display: 2022-02-08
Authors：Amraei, R; Xia, C; Olejnik, J; White, M R; Napoleon, M A; Lotfollahzadeh, S; etc.
Date Display: 2022-02-08
Title：Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein
Authors：Shi, Y; Zeida, A; Edwards, C E; Mallory, M L; Sastre, S; Machado, M R; etc.
Date Display: 2022-02-08
Authors：Shi, Y; Zeida, A; Edwards, C E; Mallory, M L; Sastre, S; Machado, M R; etc.
Date Display: 2022-02-08
Title：Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2
Authors：Ringlander, J; Fingal, J; Kann, H; Prakash, K; Rydell, G; Andersson, M; etc.
Date Display: 2022-02-08
Authors：Ringlander, J; Fingal, J; Kann, H; Prakash, K; Rydell, G; Andersson, M; etc.
Date Display: 2022-02-08
Title：A 680,000-person megastudy of nudges to encourage vaccination in pharmacies
Authors：Milkman, K L; Gandhi, L; Patel, M S; Graci, H N; Gromet, D M; Ho, H; etc.
Date Display: 2022-02-08
Authors：Milkman, K L; Gandhi, L; Patel, M S; Graci, H N; Gromet, D M; Ho, H; etc.
Date Display: 2022-02-08
Title：Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2
Authors：Schultz, D C; Johnson, R M; Ayyanathan, K; Miller, J; Whig, K; etc.
Date Display: 2022-02-07
Authors：Schultz, D C; Johnson, R M; Ayyanathan, K; Miller, J; Whig, K; etc.
Date Display: 2022-02-07
Title：Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
Authors：Costa, Clemens SA; Weckx, L; Clemens, R; Almeida, Mendes AV; etc.
Date Display: 2022-02-05
Authors：Costa, Clemens SA; Weckx, L; Clemens, R; Almeida, Mendes AV; etc.
Date Display: 2022-02-05
Title：T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
Authors：Naranbhai, V; Nathan, A; Kaseke, C; Berrios, C; Khatri, A; Choi, S; etc.
Date Display: 2022-02-03
Authors：Naranbhai, V; Nathan, A; Kaseke, C; Berrios, C; Khatri, A; Choi, S; etc.
Date Display: 2022-02-03
Title：mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Authors：Garcia-Beltran, W F; St, Denis KJ; Hoelzemer, A; Lam, E C; Nitido, A D; etc.
Date Display: 2022-02-03
Authors：Garcia-Beltran, W F; St, Denis KJ; Hoelzemer, A; Lam, E C; Nitido, A D; etc.
Date Display: 2022-02-03
Title：Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak
Authors：Siddle, K J; Krasilnikova, L A; Moreno, G K; Schaffner, S F; Vostok, J; etc.
Date Display: 2022-02-03
Authors：Siddle, K J; Krasilnikova, L A; Moreno, G K; Schaffner, S F; Vostok, J; etc.
Date Display: 2022-02-03
Title：SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Authors：Dejnirattisai, W; Huo, J; Zhou, D; Zahradn¨ªk, J; Supasa, P; Liu, C; etc.
Date Display: 2022-02-03
Authors：Dejnirattisai, W; Huo, J; Zhou, D; Zahradn¨ªk, J; Supasa, P; Liu, C; etc.
Date Display: 2022-02-03
Title：The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Authors：Hoffmann, M; Kr¨¹ger, N; Schulz, S; Cossmann, A; Rocha, C; Kempf, A; etc.
Date Display: 2022-02-03
Authors：Hoffmann, M; Kr¨¹ger, N; Schulz, S; Cossmann, A; Rocha, C; Kempf, A; etc.
Date Display: 2022-02-03
Title：Complement activation induces excessive T cell cytotoxicity in severe COVID-19
Authors：Georg, P; Astaburuaga-Garc¨ªa, R; Bonaguro, L; Brumhard, S; etc.
Date Display: 2022-02-03
Authors：Georg, P; Astaburuaga-Garc¨ªa, R; Bonaguro, L; Brumhard, S; etc.
Date Display: 2022-02-03
Title：Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Authors：Lederer, K; Bettini, E; Parvathaneni, K; Painter, M M; Agarwal, D; etc.
Date Display: 2022-02-02
Authors：Lederer, K; Bettini, E; Parvathaneni, K; Painter, M M; Agarwal, D; etc.
Date Display: 2022-02-02
Title：Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Authors：Carre?o, J M; Alshammary, H; Tcheou, J; Singh, G; Raskin, A J; etc.
Date Display: 2022-02-01
Authors：Carre?o, J M; Alshammary, H; Tcheou, J; Singh, G; Raskin, A J; etc.
Date Display: 2022-02-01
Title：Evolution of enhanced innate immune evasion by SARS-CoV-2
Authors：Thorne, L G; Bouhaddou, M; Reuschl, A K; Zuliani-Alvarez, L; etc.
Date Display: 2022-02-01
Authors：Thorne, L G; Bouhaddou, M; Reuschl, A K; Zuliani-Alvarez, L; etc.
Date Display: 2022-02-01
Title：Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
Authors：Meng, B; Abdullahi, A; Ferreira, IATM; Goonawardane, N; Saito, A; etc.
Date Display: 2022-02-01
Authors：Meng, B; Abdullahi, A; Ferreira, IATM; Goonawardane, N; Saito, A; etc.
Date Display: 2022-02-01
Title：Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Authors：Cameroni, E; Bowen, J E; Rosen, L E; Saliba, C; Zepeda, S K; Culap, K; etc.
Date Display: 2022-02-01
Authors：Cameroni, E; Bowen, J E; Rosen, L E; Saliba, C; Zepeda, S K; Culap, K; etc.
Date Display: 2022-02-01
Title：Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Authors：Cele, S; Jackson, L; Khoury, D S; Khan, K; Moyo-Gwete, T; Tegally, H; etc.
Date Display: 2022-02-01
Authors：Cele, S; Jackson, L; Khoury, D S; Khan, K; Moyo-Gwete, T; Tegally, H; etc.
Date Display: 2022-02-01
Title：Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
Authors：Saito, A; Irie, T; Suzuki, R; Maemura, T; Nasser, H; Uriu, K; Kosugi, Y; etc.
Date Display: 2022-02-01
Authors：Saito, A; Irie, T; Suzuki, R; Maemura, T; Nasser, H; Uriu, K; Kosugi, Y; etc.
Date Display: 2022-02-01
Title：Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Authors：Planas, D; Saunders, N; Maes, P; Guivel-Benhassine, F; Planchais, C; etc.
Date Display: 2022-02-01
Authors：Planas, D; Saunders, N; Maes, P; Guivel-Benhassine, F; Planchais, C; etc.
Date Display: 2022-02-01
Title：Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Authors：Cao, Y; Wang, J; Jian, F; Xiao, T; Song, W; Yisimayi, A; Huang, W; etc.
Date Display: 2022-02-01
Authors：Cao, Y; Wang, J; Jian, F; Xiao, T; Song, W; Yisimayi, A; Huang, W; etc.
Date Display: 2022-02-01
Title：Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Authors：Suzuki, R; Yamasoba, D; Kimura, I; Wang, L; Kishimoto, M; Ito, J; etc.
Date Display: 2022-02-01
Authors：Suzuki, R; Yamasoba, D; Kimura, I; Wang, L; Kishimoto, M; Ito, J; etc.
Date Display: 2022-02-01
Title：Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial
Authors：O'Brien, M P; Forleo-Neto, E; Sarkar, N; Isa, F; Hou, P; Chan, K C; etc.
Date Display: 2022-02-01
Authors：O'Brien, M P; Forleo-Neto, E; Sarkar, N; Isa, F; Hou, P; Chan, K C; etc.
Date Display: 2022-02-01
Title：Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron
Authors：Liu, J; Chandrashekar, A; Sellers, D; Barrett, J; Jacob-Dolan, C; etc.
Date Display: 2022-01-31
Authors：Liu, J; Chandrashekar, A; Sellers, D; Barrett, J; Jacob-Dolan, C; etc.
Date Display: 2022-01-31
Title：T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Authors：Keeton, R; Tincho, M B; Ngomti, A; Baguma, R; Benede, N; Suzuki, A; etc.
Date Display: 2022-01-31
Authors：Keeton, R; Tincho, M B; Ngomti, A; Baguma, R; Benede, N; Suzuki, A; etc.
Date Display: 2022-01-31
Title：Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Authors：Bravo, L; Smolenov, I; Han, H H; Li, P; Hosain, R; Rockhold, F; etc.
Date Display: 2022-01-29
Authors：Bravo, L; Smolenov, I; Han, H H; Li, P; Hosain, R; Rockhold, F; etc.
Date Display: 2022-01-29
Title：Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Authors：Park, Y J; De Marco, A; Starr, T N; Liu, Z; Pinto, D; Walls, A C; Zatta, F; etc.
Date Display: 2022-01-28
Authors：Park, Y J; De Marco, A; Starr, T N; Liu, Z; Pinto, D; Walls, A C; Zatta, F; etc.
Date Display: 2022-01-28
Title：Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
Authors：Wang, K; Jia, Z; Bao, L; Wang, L; Cao, L; Chi, H; Hu, Y; Li, Q; Jiang, Y; etc.
Date Display: 2022-01-28
Authors：Wang, K; Jia, Z; Bao, L; Wang, L; Cao, L; Chi, H; Hu, Y; Li, Q; Jiang, Y; etc.
Date Display: 2022-01-28
Title：Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Authors：Andrews, N; Tessier, E; Stowe, J; Gower, C; Kirsebom, F; Simmons, R; etc.
Date Display: 2022-01-27
Authors：Andrews, N; Tessier, E; Stowe, J; Gower, C; Kirsebom, F; Simmons, R; etc.
Date Display: 2022-01-27
Title：Homologous and Heterologous Covid-19 Booster Vaccinations
Authors：Atmar, R L; Lyke, K E; Deming, M E; Jackson, L A; Branche, A R; etc.
Date Display: 2022-01-26
Authors：Atmar, R L; Lyke, K E; Deming, M E; Jackson, L A; Branche, A R; etc.
Date Display: 2022-01-26
Title：Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes
Authors：Rodriguez-Rivas, J; Croce, G; Muscat, M; Weigt, M
Date Display: 2022-01-25
Authors：Rodriguez-Rivas, J; Croce, G; Muscat, M; Weigt, M
Date Display: 2022-01-25
Title：SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry
Authors：Yang, B; Jia, Y; Meng, Y; Xue, Y; Liu, K; Li, Y; Liu, S; Li, X; Cui, K; Shang, L; etc.
Date Display: 2022-01-25
Authors：Yang, B; Jia, Y; Meng, Y; Xue, Y; Liu, K; Li, Y; Liu, S; Li, X; Cui, K; Shang, L; etc.
Date Display: 2022-01-25
Title：Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel
Authors：Spitzer, A; Angel, Y; Marudi, O; Zeltser, D; Saiag, E; Goldshmidt, H; etc.
Date Display: 2022-01-25
Authors：Spitzer, A; Angel, Y; Marudi, O; Zeltser, D; Saiag, E; Goldshmidt, H; etc.
Date Display: 2022-01-25
Title：Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Authors：R?ltgen, K; Nielsen, SCA; Silva, O; Younes, S F; Zaslavsky, M; Costales, C; etc.
Date Display: 2022-01-25
Authors：R?ltgen, K; Nielsen, SCA; Silva, O; Younes, S F; Zaslavsky, M; Costales, C; etc.
Date Display: 2022-01-25
Title：SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Authors：Cohn, B A; Cirillo, P M; Murphy, C C; Krigbaum, N Y; Wallace, A W
Date Display: 2022-01-21
Authors：Cohn, B A; Cirillo, P M; Murphy, C C; Krigbaum, N Y; Wallace, A W
Date Display: 2022-01-21
Title：Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Authors：Nabel, K G; Clark, S A; Shankar, S; Pan, J; Clark, L E; Yang, P; Coscia, A; etc.
Date Display: 2022-01-21
Authors：Nabel, K G; Clark, S A; Shankar, S; Pan, J; Clark, L E; Yang, P; Coscia, A; etc.
Date Display: 2022-01-21
Title：Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave
Authors：Hupert, N; Mar¨ªn-Hern¨¢ndez, D; Gao, B; ¨¢guas, R; Nixon, D F
Date Display: 2022-01-18
Authors：Hupert, N; Mar¨ªn-Hern¨¢ndez, D; Gao, B; ¨¢guas, R; Nixon, D F
Date Display: 2022-01-18
Title：Targeted vaccination and the speed of SARS-CoV-2 adaptation
Authors：Gandon, S; Lion, S
Date Display: 2022-01-18
Authors：Gandon, S; Lion, S
Date Display: 2022-01-18
Title：Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
Authors：Reynolds, C J; Gibbons, J M; Pade, C; Lin, K M; Sandoval, D M; Pieper, F; etc.
Date Display: 2022-01-14
Authors：Reynolds, C J; Gibbons, J M; Pade, C; Lin, K M; Sandoval, D M; Pieper, F; etc.
Date Display: 2022-01-14
Title：Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data
Authors：McNamara, L A; Wiegand, R E; Burke, R M; Sharma, A J; Sheppard, M; etc.
Date Display: 2022-01-08
Authors：McNamara, L A; Wiegand, R E; Burke, R M; Sharma, A J; Sheppard, M; etc.
Date Display: 2022-01-08
Title：Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Authors：Gilbert, P B; Montefiori, D C; McDermott, A B; Fong, Y; Benkeser, D; etc.
Date Display: 2022-01-07
Authors：Gilbert, P B; Montefiori, D C; McDermott, A B; Fong, Y; Benkeser, D; etc.
Date Display: 2022-01-07
Title：Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
Authors：Gagne, M; Corbett, K S; Flynn, B J; Foulds, K E; Wagner, D A; Andrew, S F; etc.
Date Display: 2022-01-06
Authors：Gagne, M; Corbett, K S; Flynn, B J; Foulds, K E; Wagner, D A; Andrew, S F; etc.
Date Display: 2022-01-06
Title：A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface
Authors：Leon, J; Michelson, D A; Olejnik, J; Chowdhary, K; Oh, H S; Hume, A J; etc.
Date Display: 2022-01-04
Authors：Leon, J; Michelson, D A; Olejnik, J; Chowdhary, K; Oh, H S; Hume, A J; etc.
Date Display: 2022-01-04
Title：SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation
Authors：Yu, S; Zheng, X; Zhou, B; Li, J; Chen, M; Deng, R; Wong, G; Lavillette, D; Meng, G
Date Display: 2022-01-04
Authors：Yu, S; Zheng, X; Zhou, B; Li, J; Chen, M; Deng, R; Wong, G; Lavillette, D; Meng, G
Date Display: 2022-01-04
Title：Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Authors：Swadling, L; Diniz, M O; Schmidt, N M; Amin, O E; Chandran, A; etc.
Date Display: 2022-01-01
Authors：Swadling, L; Diniz, M O; Schmidt, N M; Amin, O E; Chandran, A; etc.
Date Display: 2022-01-01
Title：A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Authors：Heitmann, J S; Bilich, T; Tandler, C; Nelde, A; Maringer, Y; Marconato, M; etc.
Date Display: 2022-01-01
Authors：Heitmann, J S; Bilich, T; Tandler, C; Nelde, A; Maringer, Y; Marconato, M; etc.
Date Display: 2022-01-01
Title：Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Authors：Stuart, ASV; Shaw, R H; Liu, X; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2022-01-01
Authors：Stuart, ASV; Shaw, R H; Liu, X; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2022-01-01
Title：Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil
Authors：Katikireddi, S V; Cerqueira-Silva, T; Vasileiou, E; Robertson, C; Amele, S; etc.
Date Display: 2022-01-01
Authors：Katikireddi, S V; Cerqueira-Silva, T; Vasileiou, E; Robertson, C; Amele, S; etc.
Date Display: 2022-01-01
Title：SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes
Authors：Pawlica, P; Yario, T A; White, S; Wang, J; Moss, W N; Hui, P; etc.
Date Display: 2021-12-28
Authors：Pawlica, P; Yario, T A; White, S; Wang, J; Moss, W N; Hui, P; etc.
Date Display: 2021-12-28
Title：SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes
Authors：Pawlica, P; Yario, T A; White, S; Wang, J; Moss, W N; Hui, P; Vinetz, J M; Steitz, J A
Date Display: 2021-12-28
Authors：Pawlica, P; Yario, T A; White, S; Wang, J; Moss, W N; Hui, P; Vinetz, J M; Steitz, J A
Date Display: 2021-12-28
Title：The role of non-COVID-specific and COVID-specific factors in predicting a shift in willingness to vaccinate: A panel study
Authors：Jamieson, K H; Romer, D; Jamieson, P E; Winneg, K M; Pasek, J
Date Display: 2021-12-28
Authors：Jamieson, K H; Romer, D; Jamieson, P E; Winneg, K M; Pasek, J
Date Display: 2021-12-28
Title：Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles
Authors：Syed, A M; Taha, T Y; Tabata, T; Chen, I P; Ciling, A; Khalid, M M; etc.
Date Display: 2021-12-24
Authors：Syed, A M; Taha, T Y; Tabata, T; Chen, I P; Ciling, A; Khalid, M M; etc.
Date Display: 2021-12-24
Title：Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
Authors：McCallum, M; Walls, A C; Sprouse, K R; Bowen, J E; Rosen, L E; etc.
Date Display: 2021-12-24
Authors：McCallum, M; Walls, A C; Sprouse, K R; Bowen, J E; Rosen, L E; etc.
Date Display: 2021-12-24
Title：Protection against Covid-19 by BNT162b2 Booster across Age Groups
Authors：Bar-On, Y M; Goldberg, Y; Mandel, M; Bodenheimer, O; Freedman, L; etc.
Date Display: 2021-12-23
Authors：Bar-On, Y M; Goldberg, Y; Mandel, M; Bodenheimer, O; Freedman, L; etc.
Date Display: 2021-12-23
Title：BNT162b2 Vaccine Booster and Mortality Due to Covid-19
Authors：Arbel, R; Hammerman, A; Sergienko, R; Friger, M; Peretz, A; etc.
Date Display: 2021-12-23
Authors：Arbel, R; Hammerman, A; Sergienko, R; Friger, M; Peretz, A; etc.
Date Display: 2021-12-23
Title：Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase
Authors：Prugger, C; Spelsberg, A; Keil, U; Erviti, J; Doshi, P
Date Display: 2021-12-23
Authors：Prugger, C; Spelsberg, A; Keil, U; Erviti, J; Doshi, P
Date Display: 2021-12-23
Title：Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape
Authors：Bushman, M; Kahn, R; Taylor, B P; Lipsitch, M; Hanage, W P
Date Display: 2021-12-22
Authors：Bushman, M; Kahn, R; Taylor, B P; Lipsitch, M; Hanage, W P
Date Display: 2021-12-22
Title：Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat
Authors：Chandran, V; Berm¨²dez, M L; Koka, M; Chandran, B; Pawale, D; etc.
Date Display: 2021-12-21
Authors：Chandran, V; Berm¨²dez, M L; Koka, M; Chandran, B; Pawale, D; etc.
Date Display: 2021-12-21
Title：Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
Authors：Lazarus, R; Baos, S; Cappel-Porter, H; Carson-Stevens, A; Clout, M; etc.
Date Display: 2021-12-18
Authors：Lazarus, R; Baos, S; Cappel-Porter, H; Carson-Stevens, A; Clout, M; etc.
Date Display: 2021-12-18
Title：Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Authors：Munro, APS; Janani, L; Cornelius, V; Aley, P K; Babbage, G; Baxter, D; etc.
Date Display: 2021-12-18
Authors：Munro, APS; Janani, L; Cornelius, V; Aley, P K; Babbage, G; Baxter, D; etc.
Date Display: 2021-12-18
Title：SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study
Authors：Husby, A; Hansen, J V; Fosb?l, E; Thiesson, E M; Madsen, M; etc.
Date Display: 2021-12-16
Authors：Husby, A; Hansen, J V; Fosb?l, E; Thiesson, E M; Madsen, M; etc.
Date Display: 2021-12-16
Title：SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study
Authors：Husby, A; Hansen, J V; Fosb?l, E; Thiesson, E M; Madsen, M; etc.
Date Display: 2021-12-16
Authors：Husby, A; Hansen, J V; Fosb?l, E; Thiesson, E M; Madsen, M; etc.
Date Display: 2021-12-16
Title：Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
Authors：Bruxvoort, K J; Sy, L S; Qian, L; Ackerson, B K; Luo, Y; Lee, G S; etc.
Date Display: 2021-12-15
Authors：Bruxvoort, K J; Sy, L S; Qian, L; Ackerson, B K; Luo, Y; Lee, G S; etc.
Date Display: 2021-12-15
Title：Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
Authors：Bruxvoort, K J; Sy, L S; Qian, L; Ackerson, B K; Luo, Y; Lee, G S; etc.
Date Display: 2021-12-15
Authors：Bruxvoort, K J; Sy, L S; Qian, L; Ackerson, B K; Luo, Y; Lee, G S; etc.
Date Display: 2021-12-15
Title：A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry
Authors：Valero, J; Civit, L; Dupont, D M; Selnihhin, D; Reinert, L S; Idorn, M; etc.
Date Display: 2021-12-14
Authors：Valero, J; Civit, L; Dupont, D M; Selnihhin, D; Reinert, L S; Idorn, M; etc.
Date Display: 2021-12-14
Title：A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters
Authors：Liu, X; Luongo, C; Matsuoka, Y; Park, H S; Santos, C; Yang, L; Moore, I N; etc.
Date Display: 2021-12-14
Authors：Liu, X; Luongo, C; Matsuoka, Y; Park, H S; Santos, C; Yang, L; Moore, I N; etc.
Date Display: 2021-12-14
Title：Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells
Authors：Chen, J; Fan, J; Chen, Z; Zhang, M; Peng, H; Liu, J; Ding, L; Liu, M; etc.
Date Display: 2021-12-14
Authors：Chen, J; Fan, J; Chen, Z; Zhang, M; Peng, H; Liu, J; Ding, L; Liu, M; etc.
Date Display: 2021-12-14
Title：A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters
Authors：Liu, X; Luongo, C; Matsuoka, Y; Park, H S; Santos, C; Yang, L; Moore, I N; etc.
Date Display: 2021-12-14
Authors：Liu, X; Luongo, C; Matsuoka, Y; Park, H S; Santos, C; Yang, L; Moore, I N; etc.
Date Display: 2021-12-14
Title：A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry
Authors：Valero, J; Civit, L; Dupont, D M; Selnihhin, D; Reinert, L S; Idorn, M; etc.
Date Display: 2021-12-14
Authors：Valero, J; Civit, L; Dupont, D M; Selnihhin, D; Reinert, L S; Idorn, M; etc.
Date Display: 2021-12-14
Title：Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells
Authors：Chen, J; Fan, J; Chen, Z; Zhang, M; Peng, H; Liu, J; Ding, L; Liu, M; etc.
Date Display: 2021-12-14
Authors：Chen, J; Fan, J; Chen, Z; Zhang, M; Peng, H; Liu, J; Ding, L; Liu, M; etc.
Date Display: 2021-12-14
Title：Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
Authors：Ella, R; Reddy, S; Blackwelder, W; Potdar, V; Yadav, P; Sarangi, V; etc.
Date Display: 2021-12-11
Authors：Ella, R; Reddy, S; Blackwelder, W; Potdar, V; Yadav, P; Sarangi, V; etc.
Date Display: 2021-12-11
Title：Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Authors：Omer, S B; Benjamin, R M; Brewer, N T; Buttenheim, A M; etc.
Date Display: 2021-12-11
Authors：Omer, S B; Benjamin, R M; Brewer, N T; Buttenheim, A M; etc.
Date Display: 2021-12-11
Title：Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Authors：Omer, S B; Benjamin, R M; Brewer, N T; Buttenheim, A M; etc.
Date Display: 2021-12-11
Authors：Omer, S B; Benjamin, R M; Brewer, N T; Buttenheim, A M; etc.
Date Display: 2021-12-11
Title：Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
Authors：Ella, R; Reddy, S; Blackwelder, W; Potdar, V; Yadav, P; Sarangi, V; etc.
Date Display: 2021-12-11
Authors：Ella, R; Reddy, S; Blackwelder, W; Potdar, V; Yadav, P; Sarangi, V; etc.
Date Display: 2021-12-11
Title：A defective viral genome strategy elicits broad protective immunity against respiratory viruses
Authors：Xiao, Y; Lidsky, P V; Shirogane, Y; Aviner, R; Wu, C T; Li, W; Zheng, W; etc.
Date Display: 2021-12-09
Authors：Xiao, Y; Lidsky, P V; Shirogane, Y; Aviner, R; Wu, C T; Li, W; Zheng, W; etc.
Date Display: 2021-12-09
Title：Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance
Authors：Chaturvedi, S; Vasen, G; Pablo, M; Chen, X; Beutler, N; Kumar, A; etc.
Date Display: 2021-12-09
Authors：Chaturvedi, S; Vasen, G; Pablo, M; Chen, X; Beutler, N; Kumar, A; etc.
Date Display: 2021-12-09
Title：A defective viral genome strategy elicits broad protective immunity against respiratory viruses
Authors：Xiao, Y; Lidsky, P V; Shirogane, Y; Aviner, R; Wu, C T; Li, W; Zheng, W; etc.
Date Display: 2021-12-09
Authors：Xiao, Y; Lidsky, P V; Shirogane, Y; Aviner, R; Wu, C T; Li, W; Zheng, W; etc.
Date Display: 2021-12-09
Title：BNT162b2 Vaccine Booster and Mortality Due to Covid-19
Authors：Arbel, R; Hammerman, A; Sergienko, R; Friger, M; Peretz, A; Netzer, D; Yaron, S
Date Display: 2021-12-08
Authors：Arbel, R; Hammerman, A; Sergienko, R; Friger, M; Peretz, A; Netzer, D; Yaron, S
Date Display: 2021-12-08
Title：Protection against Covid-19 by BNT162b2 Booster across Age Groups
Authors：Bar-On, Y M; Goldberg, Y; Mandel, M; Bodenheimer, O; etc.
Date Display: 2021-12-08
Authors：Bar-On, Y M; Goldberg, Y; Mandel, M; Bodenheimer, O; etc.
Date Display: 2021-12-08
Title：Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial
Authors：Krzyzanowska, M K; Julian, J A; Gu, C S; Powis, M; Li, Q; Enright, K; etc.
Date Display: 2021-12-08
Authors：Krzyzanowska, M K; Julian, J A; Gu, C S; Powis, M; Li, Q; Enright, K; etc.
Date Display: 2021-12-08
Title：Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021
Authors：Bokemper, S E; Gerber, A S; Omer, S B; Huber, G A
Date Display: 2021-12-07
Authors：Bokemper, S E; Gerber, A S; Omer, S B; Huber, G A
Date Display: 2021-12-07
Title：Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021
Authors：Bokemper, S E; Gerber, A S; Omer, S B; Huber, G A
Date Display: 2021-12-07
Authors：Bokemper, S E; Gerber, A S; Omer, S B; Huber, G A
Date Display: 2021-12-07
Title：Religious identity cues increase vaccination intentions and trust in medical experts among American Christians
Authors：Chu, J; Pink, S L; Willer, R
Date Display: 2021-12-07
Authors：Chu, J; Pink, S L; Willer, R
Date Display: 2021-12-07
Title：In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness
Authors：Ke, R; Zitzmann, C; Ho, D D; Ribeiro, R M; Perelson, A S
Date Display: 2021-12-07
Authors：Ke, R; Zitzmann, C; Ho, D D; Ribeiro, R M; Perelson, A S
Date Display: 2021-12-07
Title：Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication
Authors：Ogando, N S; El, Kazzi P; Zevenhoven-Dobbe, J C; Bontes, B W; etc.
Date Display: 2021-12-07
Authors：Ogando, N S; El, Kazzi P; Zevenhoven-Dobbe, J C; Bontes, B W; etc.
Date Display: 2021-12-07
Title：Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years
Authors：Eliakim-Raz, N; Leibovici-Weisman, Y; Stemmer, A; Ness, A; etc.
Date Display: 2021-12-07
Authors：Eliakim-Raz, N; Leibovici-Weisman, Y; Stemmer, A; Ness, A; etc.
Date Display: 2021-12-07
Title：Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Authors：Stuart, ASV; Shaw, R H; Liu, X; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2021-12-06
Authors：Stuart, ASV; Shaw, R H; Liu, X; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2021-12-06
Title：Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Authors：Barda, N; Dagan, N; Cohen, C; Hern¨¢n, M A; Lipsitch, M; Kohane, I S; etc.
Date Display: 2021-12-04
Authors：Barda, N; Dagan, N; Cohen, C; Hern¨¢n, M A; Lipsitch, M; Kohane, I S; etc.
Date Display: 2021-12-04
Title：Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Authors：Barda, N; Dagan, N; Cohen, C; Hern¨¢n, M A; Lipsitch, M; etc.
Date Display: 2021-12-04
Authors：Barda, N; Dagan, N; Cohen, C; Hern¨¢n, M A; Lipsitch, M; etc.
Date Display: 2021-12-04
Title：Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
Authors：Gagne, M; Corbett, K S; Flynn, B J; Foulds, K E; Wagner, D A; etc.
Date Display: 2021-12-03
Authors：Gagne, M; Corbett, K S; Flynn, B J; Foulds, K E; Wagner, D A; etc.
Date Display: 2021-12-03
Title：Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Authors：Munro, APS; Janani, L; Cornelius, V; Aley, P K; Babbage, G; Baxter, D;etc.
Date Display: 2021-12-02
Authors：Munro, APS; Janani, L; Cornelius, V; Aley, P K; Babbage, G; Baxter, D;etc.
Date Display: 2021-12-02
Title：Unrepresentative big surveys significantly overestimated US vaccine uptake
Authors：Bradley, V C; Kuriwaki, S; Isakov, M; Sejdinovic, D; Meng, X L; Flaxman, S
Date Display: 2021-12-01
Authors：Bradley, V C; Kuriwaki, S; Isakov, M; Sejdinovic, D; Meng, X L; Flaxman, S
Date Display: 2021-12-01
Title：Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein
Authors：Tai, L; Zhu, G; Yang, M; Cao, L; Xing, X; Yin, G; Chan, C; Qin, C; Rao, Z; etc.
Date Display: 2021-11-30
Authors：Tai, L; Zhu, G; Yang, M; Cao, L; Xing, X; Yin, G; Chan, C; Qin, C; Rao, Z; etc.
Date Display: 2021-11-30
Title：Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein
Authors：Tai, L; Zhu, G; Yang, M; Cao, L; Xing, X; Yin, G; Chan, C; Qin, C; etc.
Date Display: 2021-11-30
Authors：Tai, L; Zhu, G; Yang, M; Cao, L; Xing, X; Yin, G; Chan, C; Qin, C; etc.
Date Display: 2021-11-30
Title：Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study
Authors：Israel, A; Merzon, E; Sch?ffer, A A; Shenhar, Y; Green, I; Golan-Cohen, A; etc.
Date Display: 2021-11-24
Authors：Israel, A; Merzon, E; Sch?ffer, A A; Shenhar, Y; Green, I; Golan-Cohen, A; etc.
Date Display: 2021-11-24
Title：Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study
Authors：Israel, A; Merzon, E; Sch?ffer, A A; Shenhar, Y; Green, I; Golan-Cohen, A; etc.
Date Display: 2021-11-24
Authors：Israel, A; Merzon, E; Sch?ffer, A A; Shenhar, Y; Green, I; Golan-Cohen, A; etc.
Date Display: 2021-11-24
Title：A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Authors：Heitmann, J S; Bilich, T; Tandler, C; Nelde, A; Maringer, Y; Marconato, M; etc.
Date Display: 2021-11-23
Authors：Heitmann, J S; Bilich, T; Tandler, C; Nelde, A; Maringer, Y; Marconato, M; etc.
Date Display: 2021-11-23
Title：Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Authors：Tenforde, M W; Self, W H; Adams, K; Gaglani, M; Ginde, A A; etc.
Date Display: 2021-11-23
Authors：Tenforde, M W; Self, W H; Adams, K; Gaglani, M; Ginde, A A; etc.
Date Display: 2021-11-23
Title：Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation
Authors：Zhang, L; Mann, M; Syed, Z A; Reynolds, H M; Tian, E; Samara, N L; etc.
Date Display: 2021-11-23
Authors：Zhang, L; Mann, M; Syed, Z A; Reynolds, H M; Tian, E; Samara, N L; etc.
Date Display: 2021-11-23
Title：Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Authors：Tenforde, M W; Self, W H; Adams, K; Gaglani, M; Ginde, A A; etc.
Date Display: 2021-11-23
Authors：Tenforde, M W; Self, W H; Adams, K; Gaglani, M; Ginde, A A; etc.
Date Display: 2021-11-23
Title：Optimization of Non-Coding Regions for a Non-Modified mRNA COVID-19 Vaccine
Authors：Gebre, M S; Rauch, S; Roth, N; Yu, J; Chandrashekar, A; etc.
Date Display: 2021-11-18
Authors：Gebre, M S; Rauch, S; Roth, N; Yu, J; Chandrashekar, A; etc.
Date Display: 2021-11-18
Title：Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
Authors：Lazarus, R; Baos, S; Cappel-Porter, H; Carson-Stevens, A; etc.
Date Display: 2021-11-11
Authors：Lazarus, R; Baos, S; Cappel-Porter, H; Carson-Stevens, A; etc.
Date Display: 2021-11-11
Title：Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Authors：Payne, R P; Longet, S; Austin, J A; Skelly, D T; Dejnirattisai, W; etc.
Date Display: 2021-11-11
Authors：Payne, R P; Longet, S; Austin, J A; Skelly, D T; Dejnirattisai, W; etc.
Date Display: 2021-11-11
Title：Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Authors：Payne, R P; Longet, S; Austin, J A; Skelly, D T; Dejnirattisai, W; Adele, S; etc.
Date Display: 2021-11-11
Authors：Payne, R P; Longet, S; Austin, J A; Skelly, D T; Dejnirattisai, W; Adele, S; etc.
Date Display: 2021-11-11
Title：Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Authors：Swadling, L; Diniz, M O; Schmidt, N M; Amin, O E; Chandran, A; etc.
Date Display: 2021-11-10
Authors：Swadling, L; Diniz, M O; Schmidt, N M; Amin, O E; Chandran, A; etc.
Date Display: 2021-11-10
Title：An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination
Authors：Xia, D; Jin, R; Byagathvalli, G; Yu, H; Ye, L; Lu, C Y; Bhamla, M S; etc.
Date Display: 2021-11-09
Authors：Xia, D; Jin, R; Byagathvalli, G; Yu, H; Ye, L; Lu, C Y; Bhamla, M S; etc.
Date Display: 2021-11-09
Title：Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data
Authors：McNamara, L A; Wiegand, R E; Burke, R M; Sharma, A J; etc.
Date Display: 2021-11-03
Authors：McNamara, L A; Wiegand, R E; Burke, R M; Sharma, A J; etc.
Date Display: 2021-11-03
Title：A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants
Authors：Pishesha, N; Harmand, T J; Rothlauf, P W; Praest, P; Alexander, R K; etc.
Date Display: 2021-11-02
Authors：Pishesha, N; Harmand, T J; Rothlauf, P W; Praest, P; Alexander, R K; etc.
Date Display: 2021-11-02
Title：Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
Authors：Sun, L; Kallolimath, S; Palt, R; Stiasny, K; Mayrhofer, P; Maresch, D; etc.
Date Display: 2021-11-02
Authors：Sun, L; Kallolimath, S; Palt, R; Stiasny, K; Mayrhofer, P; Maresch, D; etc.
Date Display: 2021-11-02
Title：Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
Authors：Abu-Raddad, L J; Chemaitelly, H; Ayoub, H H; Yassine, H M; etc.
Date Display: 2021-11-01
Authors：Abu-Raddad, L J; Chemaitelly, H; Ayoub, H H; Yassine, H M; etc.
Date Display: 2021-11-01
Title：Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
Authors：Gupta, A; Gonzalez-Rojas, Y; Juarez, E; Crespo, Casal M; Moya, J; etc.
Date Display: 2021-10-27
Authors：Gupta, A; Gonzalez-Rojas, Y; Juarez, E; Crespo, Casal M; Moya, J; etc.
Date Display: 2021-10-27
Title：Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
Authors：Sonabend, R; Whittles, L K; Imai, N; Perez-Guzman, P N; Knock, E S; etc.
Date Display: 2021-10-27
Authors：Sonabend, R; Whittles, L K; Imai, N; Perez-Guzman, P N; Knock, E S; etc.
Date Display: 2021-10-27
Title：Waning Immunity after the BNT162b2 Vaccine in Israel
Authors：Goldberg, Y; Mandel, M; Bar-On, Y M; Bodenheimer, O; Freedman, L; etc.
Date Display: 2021-10-27
Authors：Goldberg, Y; Mandel, M; Bar-On, Y M; Bodenheimer, O; Freedman, L; etc.
Date Display: 2021-10-27
Title：COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions
Authors：Urano, E; Okamura, T; Ono, C; Ueno, S; Nagata, S; Kamada, H; etc.
Date Display: 2021-10-26
Authors：Urano, E; Okamura, T; Ono, C; Ueno, S; Nagata, S; Kamada, H; etc.
Date Display: 2021-10-26
Title：Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barr¨¦ Syndrome, February-July 2021
Authors：Woo, E J; Mba-Jonas, A; Dimova, R B; Alimchandani, M; etc.
Date Display: 2021-10-26
Authors：Woo, E J; Mba-Jonas, A; Dimova, R B; Alimchandani, M; etc.
Date Display: 2021-10-26
Title：Distant residues modulate conformational opening in SARS-CoV-2 spike protein
Authors：Ray, D; "Le L"; Andricioaei, I
Date Display: 2021-10-26
Authors：Ray, D; "Le L"; Andricioaei, I
Date Display: 2021-10-26
Title：A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
Authors：Mahoney, M; Damalanka, V C; Tartell, M A; Chung, D H; Louren?o, A L; etc.
Date Display: 2021-10-26
Authors：Mahoney, M; Damalanka, V C; Tartell, M A; Chung, D H; Louren?o, A L; etc.
Date Display: 2021-10-26
Title：Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
Authors：Witkowski, M; Tizian, C; Ferreira-Gomes, M; Niemeyer, D; Jones, T C; etc.
Date Display: 2021-10-25
Authors：Witkowski, M; Tizian, C; Ferreira-Gomes, M; Niemeyer, D; Jones, T C; etc.
Date Display: 2021-10-25
Title：Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination
Authors：Pozzetto, B; Legros, V; Djebali, S; Barateau, V; Guibert, N; Villard, M; etc.
Date Display: 2021-10-21
Authors：Pozzetto, B; Legros, V; Djebali, S; Barateau, V; Guibert, N; Villard, M; etc.
Date Display: 2021-10-21
Title：Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
Authors：Andreano, E; Paciello, I; Piccini, G; Manganaro, N; Pileri, P; Hyseni, I; etc.
Date Display: 2021-10-20
Authors：Andreano, E; Paciello, I; Piccini, G; Manganaro, N; Pileri, P; Hyseni, I; etc.
Date Display: 2021-10-20
Title：Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
Authors：Liu, X; Verma, A; Garcia, G Jr; Ramage, H; Lucas, A; Myers, R L; etc.
Date Display: 2021-10-19
Authors：Liu, X; Verma, A; Garcia, G Jr; Ramage, H; Lucas, A; Myers, R L; etc.
Date Display: 2021-10-19
Title：Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2
Authors：Chen, C; Boorla, V S; Banerjee, D; Chowdhury, R; Cavener, V S; etc.
Date Display: 2021-10-19
Authors：Chen, C; Boorla, V S; Banerjee, D; Chowdhury, R; Cavener, V S; etc.
Date Display: 2021-10-19
Title：Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Authors：Tartof, S Y; Slezak, J M; Fischer, H; Hong, V; Ackerson, B K; Ranasinghe, O N; etc.
Date Display: 2021-10-16
Authors：Tartof, S Y; Slezak, J M; Fischer, H; Hong, V; Ackerson, B K; Ranasinghe, O N; etc.
Date Display: 2021-10-16
Title：Genomic reconstruction of the SARS-CoV-2 epidemic in England
Authors：V?hringer, H S; Sanderson, T; Sinnott, M; De Maio, N; Nguyen, T; etc.
Date Display: 2021-10-14
Authors：V?hringer, H S; Sanderson, T; Sinnott, M; De Maio, N; Nguyen, T; etc.
Date Display: 2021-10-14
Title：mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Authors：Goel, R R; Painter, M M; Apostolidis, S A; Mathew, D; Meng, W; etc.
Date Display: 2021-10-14
Authors：Goel, R R; Painter, M M; Apostolidis, S A; Mathew, D; Meng, W; etc.
Date Display: 2021-10-14
Title：Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Authors：Walls, A C; Miranda, M C; Sch?fer, A; Pham, M N; Greaney, A; etc.
Date Display: 2021-10-14
Authors：Walls, A C; Miranda, M C; Sch?fer, A; Pham, M N; Greaney, A; etc.
Date Display: 2021-10-14
Title：Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies)
Authors：Wu, X; Rapoport, T A
Date Display: 2021-10-12
Authors：Wu, X; Rapoport, T A
Date Display: 2021-10-12
Title：Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Authors：Lucas, C; Vogels, CBF; Yildirim, I; Rothman, J E; Lu, P; Monteiro, V; etc.
Date Display: 2021-10-11
Authors：Lucas, C; Vogels, CBF; Yildirim, I; Rothman, J E; Lu, P; Monteiro, V; etc.
Date Display: 2021-10-11
Title：Anti-SARS-CoV-2 receptor binding domain antibody evolution after mRNA vaccination
Authors：Cho, A; Muecksch, F; Schaefer-Babajew, D; Wang, Z; Finkin, S; Gaebler, C; etc.
Date Display: 2021-10-07
Authors：Cho, A; Muecksch, F; Schaefer-Babajew, D; Wang, Z; Finkin, S; Gaebler, C; etc.
Date Display: 2021-10-07
Title：Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Authors：Chemaitelly, H; Tang, P; Hasan, M R; AlMukdad, S; Yassine, H M; etc.
Date Display: 2021-10-06
Authors：Chemaitelly, H; Tang, P; Hasan, M R; AlMukdad, S; Yassine, H M; etc.
Date Display: 2021-10-06
Title：Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Authors：Witberg, G; Barda, N; Hoss, S; Richter, I; Wiessman, M; Aviv, Y; etc.
Date Display: 2021-10-06
Authors：Witberg, G; Barda, N; Hoss, S; Richter, I; Wiessman, M; Aviv, Y; etc.
Date Display: 2021-10-06
Title：Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
Authors：Levin, E G; Lustig, Y; Cohen, C; Fluss, R; Indenbaum, V; Amit, S; etc.
Date Display: 2021-10-06
Authors：Levin, E G; Lustig, Y; Cohen, C; Fluss, R; Indenbaum, V; Amit, S; etc.
Date Display: 2021-10-06
Title：Highly active engineered IgG3 antibodies against SARS-CoV-2
Authors：Kallolimath, S; Sun, L; Palt, R; Stiasny, K; Mayrhofer, P; Gruber, C; etc.
Date Display: 2021-10-01
Authors：Kallolimath, S; Sun, L; Palt, R; Stiasny, K; Mayrhofer, P; Gruber, C; etc.
Date Display: 2021-10-01
Title：REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
Authors：Weinreich, D M; Sivapalasingam, S; Norton, T; Ali, S; Gao, H; Bhore, R; etc.
Date Display: 2021-09-29
Authors：Weinreich, D M; Sivapalasingam, S; Norton, T; Ali, S; Gao, H; Bhore, R; etc.
Date Display: 2021-09-29
Title：Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy
Authors：Anderson, D E; Cui, J; Ye, Q; Huang, B; Tan, Y; Jiang, C; Zu, W; etc.
Date Display: 2021-09-28
Authors：Anderson, D E; Cui, J; Ye, Q; Huang, B; Tan, Y; Jiang, C; Zu, W; etc.
Date Display: 2021-09-28
Title：Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response
Authors：Ro?mann, L; Bagola, K; Stephen, T; Gerards, A L; Walber, B; etc.
Date Display: 2021-09-28
Authors：Ro?mann, L; Bagola, K; Stephen, T; Gerards, A L; Walber, B; etc.
Date Display: 2021-09-28
Title：Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
Authors：Perry, R J; Tamborska, A; Singh, B; Craven, B; Marigold, R; etc.
Date Display: 2021-09-25
Authors：Perry, R J; Tamborska, A; Singh, B; Craven, B; Marigold, R; etc.
Date Display: 2021-09-25
Title：Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis
Authors：Siemieniuk, R A; Bartoszko, J J; D¨ªaz, Martinez JP; Kum, E; etc.
Date Display: 2021-09-23
Authors：Siemieniuk, R A; Bartoszko, J J; D¨ªaz, Martinez JP; Kum, E; etc.
Date Display: 2021-09-23
Title：Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
Authors：King, HAD; Joyce, M G; Lakhal-Naouar, I; Ahmed, A; Cincotta, C M; etc.
Date Display: 2021-09-21
Authors：King, HAD; Joyce, M G; Lakhal-Naouar, I; Ahmed, A; Cincotta, C M; etc.
Date Display: 2021-09-21
Title：Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
Authors：Dalvie, N C; Rodriguez-Aponte, S A; Hartwell, B L; Tostanoski, L H; etc.
Date Display: 2021-09-21
Authors：Dalvie, N C; Rodriguez-Aponte, S A; Hartwell, B L; Tostanoski, L H; etc.
Date Display: 2021-09-21
Title：Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Authors：Yamin, R; Jones, A T; Hoffmann, H H; Sch?fer, A; Kao, K S; etc.
Date Display: 2021-09-21
Authors：Yamin, R; Jones, A T; Hoffmann, H H; Sch?fer, A; Kao, K S; etc.
Date Display: 2021-09-21
Title：High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Authors：Schmidt, F; Weisblum, Y; Rutkowska, M; Poston, D; Da, Silva J; etc.
Date Display: 2021-09-20
Authors：Schmidt, F; Weisblum, Y; Rutkowska, M; Poston, D; Da, Silva J; etc.
Date Display: 2021-09-20
Title：Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
Authors：Tong, P; Gautam, A; Windsor, I W; Travers, M; Chen, Y; Garcia, N; etc.
Date Display: 2021-09-16
Authors：Tong, P; Gautam, A; Windsor, I W; Travers, M; Chen, Y; Garcia, N; etc.
Date Display: 2021-09-16
Title：COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
Authors：Cevik, M; Grubaugh, N D; Iwasaki, A; Openshaw, P
Date Display: 2021-09-16
Authors：Cevik, M; Grubaugh, N D; Iwasaki, A; Openshaw, P
Date Display: 2021-09-16
Title：Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Authors：Barda, N; Dagan, N; Ben-Shlomo, Y; Kepten, E; Waxman, J; etc.
Date Display: 2021-09-16
Authors：Barda, N; Dagan, N; Ben-Shlomo, Y; Kepten, E; Waxman, J; etc.
Date Display: 2021-09-16
Title：Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
Authors：Bar-On, Y M; Goldberg, Y; Mandel, M; Bodenheimer, O; etc.
Date Display: 2021-09-15
Authors：Bar-On, Y M; Goldberg, Y; Mandel, M; Bodenheimer, O; etc.
Date Display: 2021-09-15
Title：Virus-induced senescence is driver and therapeutic target in COVID-19
Authors：Lee, S; Yu, Y; Trimpert, J; Benthani, F; Mairhofer, M; Richter-Pechanska, P; etc.
Date Display: 2021-09-13
Authors：Lee, S; Yu, Y; Trimpert, J; Benthani, F; Mairhofer, M; Richter-Pechanska, P; etc.
Date Display: 2021-09-13
Title：Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Authors：Flaxman, A; Marchevsky, N G; Jenkin, D; Aboagye, J; Aley, P K; etc.
Date Display: 2021-09-11
Authors：Flaxman, A; Marchevsky, N G; Jenkin, D; Aboagye, J; Aley, P K; etc.
Date Display: 2021-09-11
Title：SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
Authors：Andreano, E; Piccini, G; Licastro, D; Casalino, L; Johnson, N V; etc.
Date Display: 2021-09-07
Authors：Andreano, E; Piccini, G; Licastro, D; Casalino, L; Johnson, N V; etc.
Date Display: 2021-09-07
Title：Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
Authors：Mirabelli, C; Wotring, J W; Zhang, C J; McCarty, S M; Fursmidt, R; etc.
Date Display: 2021-09-07
Authors：Mirabelli, C; Wotring, J W; Zhang, C J; McCarty, S M; Fursmidt, R; etc.
Date Display: 2021-09-07
Title：DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M(pro) inhibitors
Authors：Chamakuri, S; Lu, S; Ucisik, M N; Bohren, K M; Chen, Y C; "Du HC"; etc.
Date Display: 2021-09-07
Authors：Chamakuri, S; Lu, S; Ucisik, M N; Bohren, K M; Chen, Y C; "Du HC"; etc.
Date Display: 2021-09-07
Title：Incentives can spur COVID-19 vaccination uptake
Authors：Kl¨¹ver, H; Hartmann, F; Humphreys, M; Geissler, F; Giesecke, J
Date Display: 2021-09-07
Authors：Kl¨¹ver, H; Hartmann, F; Humphreys, M; Geissler, F; Giesecke, J
Date Display: 2021-09-07
Title：SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Authors：Mlcochova, P; Kemp, S; Dhar, M S; Papa, G; Meng, B; Ferreira, IATM; etc.
Date Display: 2021-09-06
Authors：Mlcochova, P; Kemp, S; Dhar, M S; Papa, G; Meng, B; Ferreira, IATM; etc.
Date Display: 2021-09-06
Title：Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Authors：Liu, X; Shaw, R H; Stuart, ASV; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2021-09-04
Authors：Liu, X; Shaw, R H; Stuart, ASV; Greenland, M; Aley, P K; Andrews, N J; etc.
Date Display: 2021-09-04
Title：Surveillance for Adverse Events After COVID-19 mRNA Vaccination
Authors：Klein, N P; Lewis, N; Goddard, K; Fireman, B; Zerbo, O; Hanson, K E; etc.
Date Display: 2021-09-03
Authors：Klein, N P; Lewis, N; Goddard, K; Fireman, B; Zerbo, O; Hanson, K E; etc.
Date Display: 2021-09-03
Title：Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Authors：Ziegler, CGK; Miao, V N; Owings, A H; Navia, A W; Tang, Y; etc.
Date Display: 2021-09-02
Authors：Ziegler, CGK; Miao, V N; Owings, A H; Navia, A W; Tang, Y; etc.
Date Display: 2021-09-02
Title：Behavioural nudges increase COVID-19 vaccinations
Authors：Dai, H; Saccardo, S; Han, M A; Roh, L; Raja, N; Vangala, S; etc.
Date Display: 2021-09-01
Authors：Dai, H; Saccardo, S; Han, M A; Roh, L; Raja, N; Vangala, S; etc.
Date Display: 2021-09-01
Title：Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Authors：Lempp, F A; Soriaga, L; Montiel-Ruiz, M; Benigni, F; Noack, J; etc.
Date Display: 2021-08-31
Authors：Lempp, F A; Soriaga, L; Montiel-Ruiz, M; Benigni, F; Noack, J; etc.
Date Display: 2021-08-31
Title：Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Authors：Loyal, L; Braun, J; Henze, L; Kruse, B; Dingeldey, M; Reimer, U; etc.
Date Display: 2021-08-31
Authors：Loyal, L; Braun, J; Henze, L; Kruse, B; Dingeldey, M; Reimer, U; etc.
Date Display: 2021-08-31
Title：Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions
Authors：Silva, PJS; Sagastiz¨¢bal, C; Nonato, L G; Struchiner, C J; Pereira, T
Date Display: 2021-08-31
Authors：Silva, PJS; Sagastiz¨¢bal, C; Nonato, L G; Struchiner, C J; Pereira, T
Date Display: 2021-08-31
Title：Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
Authors：Hippisley-Cox, J; Patone, M; Mei, X W; Saatci, D; Dixon, S; etc.
Date Display: 2021-08-26
Authors：Hippisley-Cox, J; Patone, M; Mei, X W; Saatci, D; Dixon, S; etc.
Date Display: 2021-08-26
Title：Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity
Authors：Kim, E; Attia, Z; Woodfint, R M; Zeng, C; Kim, S H; Steiner, H E; etc.
Date Display: 2021-08-24
Authors：Kim, E; Attia, Z; Woodfint, R M; Zeng, C; Kim, S H; Steiner, H E; etc.
Date Display: 2021-08-24
Title：Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
Authors：Chung, H; He, S; Nasreen, S; Sundaram, M E; Buchan, S A; etc.
Date Display: 2021-08-20
Authors：Chung, H; He, S; Nasreen, S; Sundaram, M E; Buchan, S A; etc.
Date Display: 2021-08-20
Title：Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study
Authors：Cabezas, C; Coma, E; Mora-Fernandez, N; Li, X; Martinez-Marcos, M;etc.
Date Display: 2021-08-18
Authors：Cabezas, C; Coma, E; Mora-Fernandez, N; Li, X; Martinez-Marcos, M;etc.
Date Display: 2021-08-18
Title：Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors
Authors：Tan, C W; Chia, W N; Young, B E; Zhu, F; Lim, B L; Sia, W R; etc.
Date Display: 2021-08-18
Authors：Tan, C W; Chia, W N; Young, B E; Zhu, F; Lim, B L; Sia, W R; etc.
Date Display: 2021-08-18
Title：Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination
Authors：Agarwal, R; Dugas, M; Ramaprasad, J; Luo, J; Li, G; Gao, G G
Date Display: 2021-08-17
Authors：Agarwal, R; Dugas, M; Ramaprasad, J; Luo, J; Li, G; Gao, G G
Date Display: 2021-08-17
Title：Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
Authors：Ali, K; Berman, G; Zhou, H; Deng, W; Faughnan, V; Coronado-Voges, M; etc.
Date Display: 2021-08-11
Authors：Ali, K; Berman, G; Zhou, H; Deng, W; Faughnan, V; Coronado-Voges, M; etc.
Date Display: 2021-08-11
Title：Emphasize personal health benefits to boost COVID-19 vaccination rates
Authors：Ashworth, M; Thunstr?m, L; Cherry, T L; Newbold, S C; Finnoff, D C
Date Display: 2021-08-10
Authors：Ashworth, M; Thunstr?m, L; Cherry, T L; Newbold, S C; Finnoff, D C
Date Display: 2021-08-10
Title：Surprise dip in UK COVID cases baffles researchers
Authors：Ball, P
Date Display: 2021-08-01
Authors：Ball, P
Date Display: 2021-08-01
Title：Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
Authors：Tummino, T A; Rezelj, V V; Fischer, B; Fischer, A; O'Meara, M J; etc.
Date Display: 2021-07-30
Authors：Tummino, T A; Rezelj, V V; Fischer, B; Fischer, A; O'Meara, M J; etc.
Date Display: 2021-07-30
Title：Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine
Authors：Oberhardt, V; Luxenburger, H; Kemming, J; Schulien, I; Ciminski, K; Giese, S; etc.
Date Display: 2021-07-28
Authors：Oberhardt, V; Luxenburger, H; Kemming, J; Schulien, I; Ciminski, K; Giese, S; etc.
Date Display: 2021-07-28
Title：Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain
Authors：Staquicini, D I; Tang, FHF; Markosian, C; Yao, V J; Staquicini, F I; Dodero-Rojas, E; etc.
Date Display: 2021-07-27
Authors：Staquicini, D I; Tang, FHF; Markosian, C; Yao, V J; Staquicini, F I; Dodero-Rojas, E; etc.
Date Display: 2021-07-27
Title：Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme
Authors：Liu, C; Shi, W; Becker, S T; Schatz, D G; Liu, B; Yang, Y
Date Display: 2021-07-27
Authors：Liu, C; Shi, W; Becker, S T; Schatz, D G; Liu, B; Yang, Y
Date Display: 2021-07-27
Title：Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Authors：Lopez, Bernal J; Andrews, N; Gower, C; Gallagher, E; Simmons, R; Thelwall, S; etc.
Date Display: 2021-07-21
Authors：Lopez, Bernal J; Andrews, N; Gower, C; Gallagher, E; Simmons, R; Thelwall, S; etc.
Date Display: 2021-07-21
Title：Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
Authors：Dampalla, C S; Zheng, J; Perera, K D; Wong, L R; Meyerholz, D K; etc.
Date Display: 2021-07-20
Authors：Dampalla, C S; Zheng, J; Perera, K D; Wong, L R; Meyerholz, D K; etc.
Date Display: 2021-07-20
Title：Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
Authors：Wang, Y; Yang, C; Song, Y; Coleman, J R; Stawowczyk, M; etc.
Date Display: 2021-07-20
Authors：Wang, Y; Yang, C; Song, Y; Coleman, J R; Stawowczyk, M; etc.
Date Display: 2021-07-20
Title：Inhalable nanocatchers for SARS-CoV-2 inhibition
Authors：Zhang, H; Zhu, W; Jin, Q; Pan, F; Zhu, J; Liu, Y; Chen, L; Shen, J; Yang, Y; Chen, Q; Liu, Z
Date Display: 2021-07-20
Authors：Zhang, H; Zhu, W; Jin, Q; Pan, F; Zhu, J; Liu, Y; Chen, L; Shen, J; Yang, Y; Chen, Q; Liu, Z
Date Display: 2021-07-20
Title：Broad sarbecovirus neutralization by a human monoclonal antibody
Authors：Tortorici, M A; Czudnochowski, N; Starr, T N; Marzi, R; Walls, A C; Zatta, F; etc.
Date Display: 2021-07-19
Authors：Tortorici, M A; Czudnochowski, N; Starr, T N; Marzi, R; Walls, A C; Zatta, F; etc.
Date Display: 2021-07-19
Title：Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Authors：Tanriover, M D; Doğanay, H L; Akova, M; Güner, H R; Azap, A; Akhan, S; etc.
Date Display: 2021-07-17
Authors：Tanriover, M D; Doğanay, H L; Akova, M; Güner, H R; Azap, A; Akhan, S; etc.
Date Display: 2021-07-17
Title：SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Authors：Starr, T N; Czudnochowski, N; Liu, Z; Zatta, F; Park, Y J; Addetia, A; etc.
Date Display: 2021-07-14
Authors：Starr, T N; Czudnochowski, N; Liu, Z; Zatta, F; Park, Y J; Addetia, A; etc.
Date Display: 2021-07-14
Title：Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
Authors：Tscherne, A; Schwarz, J H; Rohde, C; Kupke, A; Kalodimou, G; etc.
Date Display: 2021-07-13
Authors：Tscherne, A; Schwarz, J H; Rohde, C; Kupke, A; Kalodimou, G; etc.
Date Display: 2021-07-13
Title：Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women
Authors：Goldshtein, I; Nevo, D; Steinberg, D M; Rotem, R S; Gorfine, M; Chodick, G; Segal, Y
Date Display: 2021-07-12
Authors：Goldshtein, I; Nevo, D; Steinberg, D M; Rotem, R S; Gorfine, M; Chodick, G; Segal, Y
Date Display: 2021-07-12
Title：Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Authors：Arunachalam, P S; Scott, MKD; Hagan, T; Li, C; Feng, Y; Wimmers, F; etc.
Date Display: 2021-07-12
Authors：Arunachalam, P S; Scott, MKD; Hagan, T; Li, C; Feng, Y; Wimmers, F; etc.
Date Display: 2021-07-12
Title：An isoform of Dicer protects mammalian stem cells against multiple RNA viruses
Authors：Poirier, E Z; Buck, M D; Chakravarty, P; Carvalho, J; Frederico, B; Cardoso, A; etc.
Date Display: 2021-07-09
Authors：Poirier, E Z; Buck, M D; Chakravarty, P; Carvalho, J; Frederico, B; Cardoso, A; etc.
Date Display: 2021-07-09
Title：Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Authors：Planas, D; Veyer, D; Baidaliuk, A; Staropoli, I; Guivel-Benhassine, F; etc.
Date Display: 2021-07-08
Authors：Planas, D; Veyer, D; Baidaliuk, A; Staropoli, I; Guivel-Benhassine, F; etc.
Date Display: 2021-07-08
Title：Antibody epitopes in vaccine-induced immune thrombotic thrombocytopenia
Authors：Huynh, A; Kelton, J G; Arnold, D M; Daka, M; Nazy, I
Date Display: 2021-07-07
Authors：Huynh, A; Kelton, J G; Arnold, D M; Daka, M; Nazy, I
Date Display: 2021-07-07
Title：Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
Authors：Jara, A; Undurraga, E A; Gonz¨¢lez, C; Paredes, F; Fontecilla, T; etc.
Date Display: 2021-07-07
Authors：Jara, A; Undurraga, E A; Gonz¨¢lez, C; Paredes, F; Fontecilla, T; etc.
Date Display: 2021-07-07
Title：SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Authors：McCallum, M; Bassi, J; De Marco, A; Chen, A; Walls, A C; etc.
Date Display: 2021-07-01
Authors：McCallum, M; Bassi, J; De Marco, A; Chen, A; Walls, A C; etc.
Date Display: 2021-07-01
Title：Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
Authors：Wang, L; Zhou, T; Zhang, Y; Yang, E S; Schramm, C A; Shi, W; etc.
Date Display: 2021-07-01
Authors：Wang, L; Zhou, T; Zhang, Y; Yang, E S; Schramm, C A; Shi, W; etc.
Date Display: 2021-07-01
Title：Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Authors：Collier, D A; Ferreira, IATM; Kotagiri, P; Datir, R; Lim, E; Touizer, E; etc.
Date Display: 2021-06-30
Authors：Collier, D A; Ferreira, IATM; Kotagiri, P; Datir, R; Lim, E; Touizer, E; etc.
Date Display: 2021-06-30
Title：Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Authors：Thompson, M G; Burgess, J L; Naleway, A L; Tyner, H; Yoon, S K; etc.
Date Display: 2021-06-30
Authors：Thompson, M G; Burgess, J L; Naleway, A L; Tyner, H; Yoon, S K; etc.
Date Display: 2021-06-30
Title：Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
Authors：Heath, P T; Galiza, E P; Baxter, D N; Boffito, M; Browne, D; etc.
Date Display: 2021-06-30
Authors：Heath, P T; Galiza, E P; Baxter, D N; Boffito, M; Browne, D; etc.
Date Display: 2021-06-30
Title：Structure-guided T?cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
Authors：Nathan, A; Rossin, E J; Kaseke, C; Park, R J; Khatri, A; Koundakjian, D; etc.
Date Display: 2021-06-30
Authors：Nathan, A; Rossin, E J; Kaseke, C; Park, R J; Khatri, A; Koundakjian, D; etc.
Date Display: 2021-06-30
Title：Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting
Authors：Sun, Y; Abriola, L; Niederer, R O; Pedersen, S F; Alfajaro, M M; etc.
Date Display: 2021-06-29
Authors：Sun, Y; Abriola, L; Niederer, R O; Pedersen, S F; Alfajaro, M M; etc.
Date Display: 2021-06-29
Title：SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Authors：Turner, J S; O'Halloran, J A; Kalaidina, E; Kim, W; Schmitz, A J; etc.
Date Display: 2021-06-28
Authors：Turner, J S; O'Halloran, J A; Kalaidina, E; Kim, W; Schmitz, A J; etc.
Date Display: 2021-06-28
Title：Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
Authors：Borobia, A M; Carcas, A J; P¨¦rez-Olmeda, M; Casta?o, L; Bertran, M J; etc.
Date Display: 2021-06-25
Authors：Borobia, A M; Carcas, A J; P¨¦rez-Olmeda, M; Casta?o, L; Bertran, M J; etc.
Date Display: 2021-06-25
Title：An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Authors：Liu, Y; Soh, W T; Kishikawa, J I; Hirose, M; Nakayama, E E; Li, S; etc.
Date Display: 2021-06-24
Authors：Liu, Y; Soh, W T; Kishikawa, J I; Hirose, M; Nakayama, E E; Li, S; etc.
Date Display: 2021-06-24
Title：Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species
Authors：Liu, K; Pan, X; Li, L; Yu, F; Zheng, A; "Du P"; Han, P; Meng, Y; Zhang, Y; etc.
Date Display: 2021-06-24
Authors：Liu, K; Pan, X; Li, L; Yu, F; Zheng, A; "Du P"; Han, P; Meng, Y; Zhang, Y; etc.
Date Display: 2021-06-24
Title：Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading
Authors：Yan, L; Yang, Y; Li, M; Zhang, Y; Zheng, L; Ge, J; Huang, Y C; etc.
Date Display: 2021-06-24
Authors：Yan, L; Yang, Y; Li, M; Zhang, Y; Zheng, L; Ge, J; Huang, Y C; etc.
Date Display: 2021-06-24
Title：Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Authors：Cai, Y; Zhang, J; Xiao, T; Lavine, C L; Rawson, S; Peng, H; Zhu, H; etc.
Date Display: 2021-06-24
Authors：Cai, Y; Zhang, J; Xiao, T; Lavine, C L; Rawson, S; Peng, H; Zhu, H; etc.
Date Display: 2021-06-24
Title：Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques
Authors：Yu, J; Tostanoski, L H; Mercado, N B; McMahan, K; Liu, J; Jacob-Dolan, C; etc.
Date Display: 2021-06-23
Authors：Yu, J; Tostanoski, L H; Mercado, N B; McMahan, K; Liu, J; Jacob-Dolan, C; etc.
Date Display: 2021-06-23
Title：Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out
Authors：Schmelz, K; Bowles, S
Date Display: 2021-06-22
Authors：Schmelz, K; Bowles, S
Date Display: 2021-06-22
Title：The total number and mass of SARS-CoV-2 virions
Authors：Sender, R; Bar-On, Y M; Gleizer, S; Bernshtein, B; Flamholz, A; Phillips, R; Milo, R
Date Display: 2021-06-22
Authors：Sender, R; Bar-On, Y M; Gleizer, S; Bernshtein, B; Flamholz, A; Phillips, R; Milo, R
Date Display: 2021-06-22
Title：Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
Authors：Martinez, D R; Sch?fer, A; Leist, S R; De la Cruz, G; West, A; etc.
Date Display: 2021-06-22
Authors：Martinez, D R; Sch?fer, A; Leist, S R; De la Cruz, G; West, A; etc.
Date Display: 2021-06-22
Title：Future of covid-19 vaccine pricing: lessons from influenza
Authors：Ramachandran, R; Dhodapkar, M; Ross, J S; Schwartz, J L
Date Display: 2021-06-22
Authors：Ramachandran, R; Dhodapkar, M; Ross, J S; Schwartz, J L
Date Display: 2021-06-22
Title：In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Authors：Chen, R E; Winkler, E S; Case, J B; Aziati, I D; Bricker, T L; Joshi, A; etc.
Date Display: 2021-06-21
Authors：Chen, R E; Winkler, E S; Case, J B; Aziati, I D; Bricker, T L; Joshi, A; etc.
Date Display: 2021-06-21
Title：In?vitro and in?vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Authors：Li, D; Edwards, R J; Manne, K; Martinez, D R; Sch?fer, A; Alam, S M; etc.
Date Display: 2021-06-18
Authors：Li, D; Edwards, R J; Manne, K; Martinez, D R; Sch?fer, A; Alam, S M; etc.
Date Display: 2021-06-18
Title：Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Authors：Liu, C; Ginn, H M; Dejnirattisai, W; Supasa, P; Wang, B; Tuekprakhon, A; etc.
Date Display: 2021-06-17
Authors：Liu, C; Ginn, H M; Dejnirattisai, W; Supasa, P; Wang, B; Tuekprakhon, A; etc.
Date Display: 2021-06-17
Title：Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein
Authors：Hsu, J C; Laurent-Rolle, M; Pawlak, J B; Wilen, C B; Cresswell, P
Date Display: 2021-06-15
Authors：Hsu, J C; Laurent-Rolle, M; Pawlak, J B; Wilen, C B; Cresswell, P
Date Display: 2021-06-15
Title：Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
Authors：Lopes, R D; de Barros, E Silva PGM; Furtado, RHM; Macedo, AVS; etc.
Date Display: 2021-06-12
Authors：Lopes, R D; de Barros, E Silva PGM; Furtado, RHM; Macedo, AVS; etc.
Date Display: 2021-06-12
Title：Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Authors：Alter, G; Yu, J; Liu, J; Chandrashekar, A; Borducchi, E N; Tostanoski, L H; etc.
Date Display: 2021-06-09
Authors：Alter, G; Yu, J; Liu, J; Chandrashekar, A; Borducchi, E N; Tostanoski, L H; etc.
Date Display: 2021-06-09
Title：The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Authors：Zhang, Y; Chen, Y; Li, Y; Huang, F; Luo, B; Yuan, Y; Xia, B; Ma, X; Yang, T; etc.
Date Display: 2021-06-08
Authors：Zhang, Y; Chen, Y; Li, Y; Huang, F; Luo, B; Yuan, Y; Xia, B; Ma, X; Yang, T; etc.
Date Display: 2021-06-08
Title：Senolytics reduce coronavirus-related mortality in old mice
Authors：Camell, C D; Yousefzadeh, M J; Zhu, Y; Langhi, Prata LGP; Huggins, M A; etc.
Date Display: 2021-06-08
Authors：Camell, C D; Yousefzadeh, M J; Zhu, Y; Langhi, Prata LGP; Huggins, M A; etc.
Date Display: 2021-06-08
Title：SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
Authors：Amanat, F; Thapa, M; Lei, T; Ahmed, SMS; Adelsberg, D C; Carre?o, J M; etc.
Date Display: 2021-06-08
Authors：Amanat, F; Thapa, M; Lei, T; Ahmed, SMS; Adelsberg, D C; Carre?o, J M; etc.
Date Display: 2021-06-08
Title：Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
Authors：Xu, J; Xu, K; Jung, S; Conte, A; Lieberman, J; Muecksch, F; Lorenzi, JCC; etc.
Date Display: 2021-06-07
Authors：Xu, J; Xu, K; Jung, S; Conte, A; Lieberman, J; Muecksch, F; Lorenzi, JCC; etc.
Date Display: 2021-06-07
Title：The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
Authors：Copin, R; Baum, A; Wloga, E; Pascal, K E; Giordano, S; Fulton, B O; etc.
Date Display: 2021-06-05
Authors：Copin, R; Baum, A; Wloga, E; Pascal, K E; Giordano, S; Fulton, B O; etc.
Date Display: 2021-06-05
Title：Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets
Authors：Maio, N; Lafont, BAP; Sil, D; Li, Y; Bollinger, JM Jr; Krebs, C; etc.
Date Display: 2021-06-03
Authors：Maio, N; Lafont, BAP; Sil, D; Li, Y; Bollinger, JM Jr; Krebs, C; etc.
Date Display: 2021-06-03
Title：Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Authors：Ku, Z; Xie, X; Hinton, P R; Liu, X; Ye, X; Muruato, A E; Ng, D C; etc.
Date Display: 2021-06-03
Authors：Ku, Z; Xie, X; Hinton, P R; Liu, X; Ye, X; Muruato, A E; Ng, D C; etc.
Date Display: 2021-06-03
Title：Profiling SARS-CoV-2 HLA-I peptidome reveals T?cell epitopes from out-of-frame ORFs
Authors：Weingarten-Gabbay, S; Klaeger, S; Sarkizova, S; Pearlman, L R; etc.
Date Display: 2021-06-03
Authors：Weingarten-Gabbay, S; Klaeger, S; Sarkizova, S; Pearlman, L R; etc.
Date Display: 2021-06-03
Title：Transfer transcriptomic signatures for infectious diseases
Authors：di Iulio, J; Bartha, I; Spreafico, R; Virgin, H W; Telenti, A
Date Display: 2021-06-01
Authors：di Iulio, J; Bartha, I; Spreafico, R; Virgin, H W; Telenti, A
Date Display: 2021-06-01
Title：Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques
Authors：He, X; Chandrashekar, A; Zahn, R; Wegmann, F; Yu, J; Mercado, N B;etc.
Date Display: 2021-06-01
Authors：He, X; Chandrashekar, A; Zahn, R; Wegmann, F; Yu, J; Mercado, N B;etc.
Date Display: 2021-06-01
Title：BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Authors：Sahin, U; Muik, A; Vogler, I; Derhovanessian, E; Kranz, L M; Vormehr, M; etc.
Date Display: 2021-05-27
Authors：Sahin, U; Muik, A; Vogler, I; Derhovanessian, E; Kranz, L M; Vormehr, M; etc.
Date Display: 2021-05-27
Title：Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Authors：Frenck, RW Jr; Klein, N P; Kitchin, N; Gurtman, A; Absalon, J; Lockhart, S; etc.
Date Display: 2021-05-27
Authors：Frenck, RW Jr; Klein, N P; Kitchin, N; Gurtman, A; Absalon, J; Lockhart, S; etc.
Date Display: 2021-05-27
Title：Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics
Authors：Chumakov, K; Avidan, M S; Benn, C S; Bertozzi, S M; Blatt, L; Chang, A Y; etc.
Date Display: 2021-05-25
Authors：Chumakov, K; Avidan, M S; Benn, C S; Bertozzi, S M; Blatt, L; Chang, A Y; etc.
Date Display: 2021-05-25
Title：2'-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography
Authors：Wilamowski, M; Sherrell, D A; Minasov, G; Kim, Y; Shuvalova, L; Lavens, A; etc.
Date Display: 2021-05-25
Authors：Wilamowski, M; Sherrell, D A; Minasov, G; Kim, Y; Shuvalova, L; Lavens, A; etc.
Date Display: 2021-05-25
Title：Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
Authors：Zhang, L; Richards, A; Barrasa, M I; Hughes, S H; Young, R A; Jaenisch, R
Date Display: 2021-05-25
Authors：Zhang, L; Richards, A; Barrasa, M I; Hughes, S H; Young, R A; Jaenisch, R
Date Display: 2021-05-25
Title：SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Authors：Turner, J S; Kim, W; Kalaidina, E; Goss, C W; Rauseo, A M; Schmitz, A J; etc.
Date Display: 2021-05-24
Authors：Turner, J S; Kim, W; Kalaidina, E; Goss, C W; Rauseo, A M; Schmitz, A J; etc.
Date Display: 2021-05-24
Title：Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Authors：Shinde, V; Bhikha, S; Hoosain, Z; Archary, M; Bhorat, Q; Fairlie, L; Lalloo, U; etc.
Date Display: 2021-05-20
Authors：Shinde, V; Bhikha, S; Hoosain, Z; Archary, M; Bhorat, Q; Fairlie, L; Lalloo, U; etc.
Date Display: 2021-05-20
Title：Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Authors：Yuan, M; Huang, D; Lee, C D; Wu, N C; Jackson, A M; Zhu, X; Liu, H; etc.
Date Display: 2021-05-20
Authors：Yuan, M; Huang, D; Lee, C D; Wu, N C; Jackson, A M; Zhu, X; Liu, H; etc.
Date Display: 2021-05-20
Title：Diverse Functional Autoantibodies in Patients with COVID-19
Authors：Wang, E Y; Mao, T; Klein, J; Dai, Y; Huck, J D; Jaycox, J R; Liu, F; Zhou, T; etc.
Date Display: 2021-05-19
Authors：Wang, E Y; Mao, T; Klein, J; Dai, Y; Huck, J D; Jaycox, J R; Liu, F; Zhou, T; etc.
Date Display: 2021-05-19
Title：Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies
Authors：Williams, W B; Meyerhoff, R R; Edwards, R J; Li, H; Manne, K; etc.
Date Display: 2021-05-18
Authors：Williams, W B; Meyerhoff, R R; Edwards, R J; Li, H; Manne, K; etc.
Date Display: 2021-05-18
Title：Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2
Authors：Low, J S; Vaqueirinho, D; Mele, F; Foglierini, M; Jerak, J; Perotti, M; etc.
Date Display: 2021-05-18
Authors：Low, J S; Vaqueirinho, D; Mele, F; Foglierini, M; Jerak, J; Perotti, M; etc.
Date Display: 2021-05-18
Title：Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Authors：Lopez, Bernal J; Andrews, N; Gower, C; Robertson, C; Stowe, J; etc.
Date Display: 2021-05-13
Authors：Lopez, Bernal J; Andrews, N; Gower, C; Robertson, C; Stowe, J; etc.
Date Display: 2021-05-13
Title：Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
Authors：Collier, A Y; McMahan, K; Yu, J; Tostanoski, L H; Aguayo, R; Ansel, J; etc.
Date Display: 2021-05-13
Authors：Collier, A Y; McMahan, K; Yu, J; Tostanoski, L H; Aguayo, R; Ansel, J; etc.
Date Display: 2021-05-13
Title：SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis
Authors：Finkel, Y; Gluck, A; Nachshon, A; Winkler, R; Fisher, T; Rozman, B; etc.
Date Display: 2021-05-12
Authors：Finkel, Y; Gluck, A; Nachshon, A; Winkler, R; Fisher, T; Rozman, B; etc.
Date Display: 2021-05-12
Title：Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Authors：Mehdipour, A R; Hummer, G
Date Display: 2021-05-11
Authors：Mehdipour, A R; Hummer, G
Date Display: 2021-05-11
Title：DNA-inspired nanomaterials for enhanced endosomal escape
Authors：Lee, J; Sands, I; Zhang, W; Zhou, L; Chen, Y
Date Display: 2021-05-11
Authors：Lee, J; Sands, I; Zhang, W; Zhou, L; Chen, Y
Date Display: 2021-05-11
Title：Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
Authors：Saunders, K O; Lee, E; Parks, R; Martinez, D R; Li, D; Chen, H; etc.
Date Display: 2021-05-10
Authors：Saunders, K O; Lee, E; Parks, R; Martinez, D R; Li, D; Chen, H; etc.
Date Display: 2021-05-10
Title：Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
Authors：Angel, Y; Spitzer, A; Henig, O; Saiag, E; Sprecher, E; Padova, H; etc.
Date Display: 2021-05-06
Authors：Angel, Y; Spitzer, A; Henig, O; Saiag, E; Sprecher, E; Padova, H; etc.
Date Display: 2021-05-06
Title：Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Authors：Shinde, V; Bhikha, S; Hoosain, Z; Archary, M; Bhorat, Q; Fairlie, L; etc.
Date Display: 2021-05-05
Authors：Shinde, V; Bhikha, S; Hoosain, Z; Archary, M; Bhorat, Q; Fairlie, L; etc.
Date Display: 2021-05-05
Title：Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
Authors：Potteg?rd, A; Lund, L C; Karlstad, ?; Dahl, J; Andersen, M; Hallas, J; etc.
Date Display: 2021-05-05
Authors：Potteg?rd, A; Lund, L C; Karlstad, ?; Dahl, J; Andersen, M; Hallas, J; etc.
Date Display: 2021-05-05
Title：Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
Authors：Voss, W N; Hou, Y J; Johnson, N V; Delidakis, G; Kim, J E; etc.
Date Display: 2021-05-04
Authors：Voss, W N; Hou, Y J; Johnson, N V; Delidakis, G; Kim, J E; etc.
Date Display: 2021-05-04
Title：A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples
Authors：Swank, Z; Michielin, G; Yip, H M; Cohen, P; Andrey, D O; etc.
Date Display: 2021-05-04
Authors：Swank, Z; Michielin, G; Yip, H M; Cohen, P; Andrey, D O; etc.
Date Display: 2021-05-04
Title：High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
Authors：Garrett, M E; Galloway, J; Chu, H Y; Itell, H L; Stoddard, C I; Wolf, C R; etc.
Date Display: 2021-05-04
Authors：Garrett, M E; Galloway, J; Chu, H Y; Itell, H L; Stoddard, C I; Wolf, C R; etc.
Date Display: 2021-05-04
Title：Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
Authors：Voss, W N; Hou, Y J; Johnson, N V; Delidakis, G; Kim, J E; Javanmardi, K; etc.
Date Display: 2021-05-04
Authors：Voss, W N; Hou, Y J; Johnson, N V; Delidakis, G; Kim, J E; Javanmardi, K; etc.
Date Display: 2021-05-04
Title：A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples
Authors：Swank, Z; Michielin, G; Yip, H M; Cohen, P; Andrey, D O; etc.
Date Display: 2021-05-04
Authors：Swank, Z; Michielin, G; Yip, H M; Cohen, P; Andrey, D O; etc.
Date Display: 2021-05-04
Title：Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Authors：Reynolds, C J; Pade, C; Gibbons, J M; Butler, D K; Otter, A D; etc.
Date Display: 2021-04-30
Authors：Reynolds, C J; Pade, C; Gibbons, J M; Butler, D K; Otter, A D; etc.
Date Display: 2021-04-30
Title：Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Authors：Reynolds, C J; Pade, C; Gibbons, J M; Butler, D K; Otter, A D; etc.
Date Display: 2021-04-30
Authors：Reynolds, C J; Pade, C; Gibbons, J M; Butler, D K; Otter, A D; etc.
Date Display: 2021-04-30
Title：US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
Authors：See, I; Su, J R; Lale, A; Woo, E J; Guh, A Y; Shimabukuro, T T; etc.
Date Display: 2021-04-30
Authors：See, I; Su, J R; Lale, A; Woo, E J; Guh, A Y; Shimabukuro, T T; etc.
Date Display: 2021-04-30
Title：COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Authors：Delorey, T M; Ziegler, CGK; Heimberg, G; Normand, R; Yang, Y; etc.
Date Display: 2021-04-29
Authors：Delorey, T M; Ziegler, CGK; Heimberg, G; Normand, R; Yang, Y; etc.
Date Display: 2021-04-29
Title：COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Authors：Delorey, T M; Ziegler, CGK; Heimberg, G; Normand, R; Yang, Y; etc.
Date Display: 2021-04-29
Authors：Delorey, T M; Ziegler, CGK; Heimberg, G; Normand, R; Yang, Y; etc.
Date Display: 2021-04-29
Title：A molecular single-cell lung atlas of lethal COVID-19
Authors：Melms, J C; Biermann, J; Huang, H; Wang, Y; Nair, A; Tagore, S; etc.
Date Display: 2021-04-29
Authors：Melms, J C; Biermann, J; Huang, H; Wang, Y; Nair, A; Tagore, S; etc.
Date Display: 2021-04-29
Title：B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
Authors：Scheid, J F; Barnes, C O; Eraslan, B; Hudak, A; Keeffe, J R; etc.
Date Display: 2021-04-24
Authors：Scheid, J F; Barnes, C O; Eraslan, B; Hudak, A; Keeffe, J R; etc.
Date Display: 2021-04-24
Title：Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia
Authors：Asarnow, D; Wang, B; Lee, W H; Hu, Y; Huang, C W; Faust, B; etc.
Date Display: 2021-04-24
Authors：Asarnow, D; Wang, B; Lee, W H; Hu, Y; Huang, C W; Faust, B; etc.
Date Display: 2021-04-24
Title：COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
Authors：Hall, V J; Foulkes, S; Saei, A; Andrews, N; Oguti, B; Charlett, A; etc.
Date Display: 2021-04-23
Authors：Hall, V J; Foulkes, S; Saei, A; Andrews, N; Oguti, B; Charlett, A; etc.
Date Display: 2021-04-23
Title：Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Authors：Hacisuleyman, E; Hale, C; Saito, Y; Blachere, N E; Bergh, M; etc.
Date Display: 2021-04-21
Authors：Hacisuleyman, E; Hale, C; Saito, Y; Blachere, N E; Bergh, M; etc.
Date Display: 2021-04-21
Title：Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
Authors：Shimabukuro, T T; Kim, S Y; Myers, T R; Moro, P L; Oduyebo, T; etc.
Date Display: 2021-04-21
Authors：Shimabukuro, T T; Kim, S Y; Myers, T R; Moro, P L; Oduyebo, T; etc.
Date Display: 2021-04-21
Title：Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Authors：Arunachalam, P S; Walls, A C; Golden, N; Atyeo, C; Fischinger, S; etc.
Date Display: 2021-04-19
Authors：Arunachalam, P S; Walls, A C; Golden, N; Atyeo, C; Fischinger, S; etc.
Date Display: 2021-04-19
Title：Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Authors：Scully, M; Singh, D; Lown, R; Poles, A; Solomon, T; Levi, M; etc.
Date Display: 2021-04-16
Authors：Scully, M; Singh, D; Lown, R; Poles, A; Solomon, T; Levi, M; etc.
Date Display: 2021-04-16
Title：Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
Authors：He, X; Quan, S; Xu, M; Rodriguez, S; Goh, S L; Wei, J; Fridman, A; etc.
Date Display: 2021-04-13
Authors：He, X; Quan, S; Xu, M; Rodriguez, S; Goh, S L; Wei, J; Fridman, A; etc.
Date Display: 2021-04-13
Title：Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
Authors：Stukalov, A; Girault, V; Grass, V; Karayel, O; Bergant, V; Urban, C; etc.
Date Display: 2021-04-12
Authors：Stukalov, A; Girault, V; Grass, V; Karayel, O; Bergant, V; Urban, C; etc.
Date Display: 2021-04-12
Title：Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Authors：Emary, KRW; Golubchik, T; Aley, P K; Ariani, C V; Angus, B; Bibi, S; etc.
Date Display: 2021-04-10
Authors：Emary, KRW; Golubchik, T; Aley, P K; Ariani, C V; Angus, B; Bibi, S; etc.
Date Display: 2021-04-10
Title：Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Authors：Greinacher, A; Thiele, T; Warkentin, T E; Weisser, K; etc.
Date Display: 2021-04-09
Authors：Greinacher, A; Thiele, T; Warkentin, T E; Weisser, K; etc.
Date Display: 2021-04-09
Title：Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia
Authors：Braga, L; Ali, H; Secco, I; Chiavacci, E; Neves, G; Goldhill, D; Penn, R; etc.
Date Display: 2021-04-07
Authors：Braga, L; Ali, H; Secco, I; Chiavacci, E; Neves, G; Goldhill, D; Penn, R; etc.
Date Display: 2021-04-07
Title：X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Authors：Günther, S; Reinke, PYA; Fernández-García, Y; Lieske, J; Lane, T J; etc.
Date Display: 2021-04-02
Authors：Günther, S; Reinke, PYA; Fernández-García, Y; Lieske, J; Lane, T J; etc.
Date Display: 2021-04-02
Title：TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation
Authors：Ho, JSY; Mok, B W; Campisi, L; Jordan, T; Yildiz, S; Parameswaran, S; etc.
Date Display: 2021-03-30
Authors：Ho, JSY; Mok, B W; Campisi, L; Jordan, T; Yildiz, S; Parameswaran, S; etc.
Date Display: 2021-03-30
Title：Antibody evasion by the P.1 strain of SARS-CoV-2
Authors：Dejnirattisai, W; Zhou, D; Supasa, P; Liu, C; Mentzer, A J; Ginn, H M; etc.
Date Display: 2021-03-30
Authors：Dejnirattisai, W; Zhou, D; Supasa, P; Liu, C; Mentzer, A J; Ginn, H M; etc.
Date Display: 2021-03-30
Title：Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Authors：Cele, S; Gazy, I; Jackson, L; Hwa, S H; Tegally, H; Lustig, G; etc.
Date Display: 2021-03-29
Authors：Cele, S; Gazy, I; Jackson, L; Hwa, S H; Tegally, H; Lustig, G; etc.
Date Display: 2021-03-29
Title：Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
Authors：De Gasparo, R; Pedotti, M; Simonelli, L; Nickl, P; Muecksch, F; etc.
Date Display: 2021-03-25
Authors：De Gasparo, R; Pedotti, M; Simonelli, L; Nickl, P; Muecksch, F; etc.
Date Display: 2021-03-25
Title：One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
Authors：Liu, R; Americo, J L; Cotter, C A; Earl, P L; Erez, N; Peng, C; Moss, B
Date Display: 2021-03-23
Authors：Liu, R; Americo, J L; Cotter, C A; Earl, P L; Erez, N; Peng, C; Moss, B
Date Display: 2021-03-23
Title：A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike
Authors：Lu, M; Dravid, P; Zhang, Y; Trivedi, S; Li, A; Harder, O; Kc, M; etc.
Date Display: 2021-03-23
Authors：Lu, M; Dravid, P; Zhang, Y; Trivedi, S; Li, A; Harder, O; Kc, M; etc.
Date Display: 2021-03-23
Title：Vaccinating the oldest against COVID-19 saves both the most lives and most years of life
Authors：Goldstein, J R; Cassidy, T; Wachter, K W
Date Display: 2021-03-16
Authors：Goldstein, J R; Cassidy, T; Wachter, K W
Date Display: 2021-03-16
Title：N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Authors：McCallum, M; De Marco, A; Lempp, F A; Tortorici, M A; Pinto, D; Walls, A C; etc.
Date Display: 2021-03-16
Authors：McCallum, M; De Marco, A; Lempp, F A; Tortorici, M A; Pinto, D; Walls, A C; etc.
Date Display: 2021-03-16
Title：Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Authors：Suryadevara, N; Shrihari, S; Gilchuk, P; VanBlargan, L A; Binshtein, E; etc.
Date Display: 2021-03-16
Authors：Suryadevara, N; Shrihari, S; Gilchuk, P; VanBlargan, L A; Binshtein, E; etc.
Date Display: 2021-03-16
Title：SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
Authors：Clark, S A; Clark, L E; Pan, J; Coscia, A; McKay, LGA; Shankar, S; etc.
Date Display: 2021-03-16
Authors：Clark, S A; Clark, L E; Pan, J; Coscia, A; McKay, LGA; Shankar, S; etc.
Date Display: 2021-03-16
Title：Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Authors：Collier, D A; De Marco, A; Ferreira, IATM; Meng, B; Datir, R; Walls, A C; etc.
Date Display: 2021-03-11
Authors：Collier, D A; De Marco, A; Ferreira, IATM; Meng, B; Datir, R; Walls, A C; etc.
Date Display: 2021-03-11
Title：Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
Authors：Stephenson, K E; Le Gars, M; Sadoff, J; de Groot, A M; Heerwegh, D; etc.
Date Display: 2021-03-11
Authors：Stephenson, K E; Le Gars, M; Sadoff, J; de Groot, A M; Heerwegh, D; etc.
Date Display: 2021-03-11
Title：Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance
Authors：Kaplan, R M; Milstein, A
Date Display: 2021-03-09
Authors：Kaplan, R M; Milstein, A
Date Display: 2021-03-09
Title：Bepridil is potent against SARS-CoV-2 in vitro
Authors：Vatansever, E C; Yang, K S; Drelich, A K; Kratch, K C; Cho, C C; etc.
Date Display: 2021-03-09
Authors：Vatansever, E C; Yang, K S; Drelich, A K; Kratch, K C; Cho, C C; etc.
Date Display: 2021-03-09
Title：Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
Authors：Saad-Roy, C M; Morris, S E; Metcalf, CJE; Mina, M J; Baker, R E; etc.
Date Display: 2021-03-09
Authors：Saad-Roy, C M; Morris, S E; Metcalf, CJE; Mina, M J; Baker, R E; etc.
Date Display: 2021-03-09
Title：Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
Authors：Wang, P; Nair, M S; Liu, L; Iketani, S; Luo, Y; Guo, Y; Wang, M; Yu, J; etc.
Date Display: 2021-03-08
Authors：Wang, P; Nair, M S; Liu, L; Iketani, S; Luo, Y; Guo, Y; Wang, M; Yu, J; etc.
Date Display: 2021-03-08
Title：The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2
Authors：Benton, D J; Wrobel, A G; Roustan, C; Borg, A; Xu, P; Martin, S R; etc.
Date Display: 2021-03-02
Authors：Benton, D J; Wrobel, A G; Roustan, C; Borg, A; Xu, P; Martin, S R; etc.
Date Display: 2021-03-02
Title：Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system
Authors：Yeung, M L; Teng, JLL; Jia, L; Zhang, C; Huang, C; Cai, J P; Zhou, R; etc.
Date Display: 2021-03-02
Authors：Yeung, M L; Teng, JLL; Jia, L; Zhang, C; Huang, C; Cai, J P; Zhou, R; etc.
Date Display: 2021-03-02
Title：A living WHO guideline on drugs to prevent covid-19
Authors：Lamontagne, F; Agoritsas, T; Siemieniuk, R; Rochwerg, B; Bartoszko, J; etc.
Date Display: 2021-03-01
Authors：Lamontagne, F; Agoritsas, T; Siemieniuk, R; Rochwerg, B; Bartoszko, J; etc.
Date Display: 2021-03-01
Title：Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Authors：Bubar, K M; Reinholt, K; Kissler, S M; Lipsitch, M; Cobey, S; Grad, Y H;etc.
Date Display: 2021-02-26
Authors：Bubar, K M; Reinholt, K; Kissler, S M; Lipsitch, M; Cobey, S; Grad, Y H;etc.
Date Display: 2021-02-26
Title：Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Authors：White, K M; Rosales, R; Yildiz, S; Kehrer, T; Miorin, L; Moreno, E; etc.
Date Display: 2021-02-26
Authors：White, K M; Rosales, R; Yildiz, S; Kehrer, T; Miorin, L; Moreno, E; etc.
Date Display: 2021-02-26
Title：BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Authors：Dagan, N; Barda, N; Kepten, E; Miron, O; Perchik, S; Katz, M A; etc.
Date Display: 2021-02-24
Authors：Dagan, N; Barda, N; Kepten, E; Miron, O; Perchik, S; Katz, M A; etc.
Date Display: 2021-02-24
Title：A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
Authors：Zhang, X; Liu, Y; Liu, J; Bailey, A L; Plante, K S; Plante, J A; Zou, J; etc.
Date Display: 2021-02-23
Authors：Zhang, X; Liu, Y; Liu, J; Bailey, A L; Plante, K S; Plante, J A; Zou, J; etc.
Date Display: 2021-02-23
Title：Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Authors：Andreano, E; Nicastri, E; Paciello, I; Pileri, P; Manganaro, N; Piccini, G; etc.
Date Display: 2021-02-23
Authors：Andreano, E; Nicastri, E; Paciello, I; Pileri, P; Manganaro, N; Piccini, G; etc.
Date Display: 2021-02-23
Title：SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Authors：Li, Q; Nie, J; Wu, J; Zhang, L; Ding, R; Wang, H; Zhang, Y; Li, T; etc.
Date Display: 2021-02-23
Authors：Li, Q; Nie, J; Wu, J; Zhang, L; Ding, R; Wang, H; Zhang, Y; Li, T; etc.
Date Display: 2021-02-23
Title：Vaccines for older adults
Authors：Cunningham, A L; McIntyre, P; Subbarao, K; Booy, R; Levin, M J
Date Display: 2021-02-22
Authors：Cunningham, A L; McIntyre, P; Subbarao, K; Booy, R; Levin, M J
Date Display: 2021-02-22
Title：Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
Authors：Richmond, P; Hatchuel, L; Dong, M; Ma, B; Hu, B; Smolenov, I; etc.
Date Display: 2021-02-20
Authors：Richmond, P; Hatchuel, L; Dong, M; Ma, B; Hu, B; Smolenov, I; etc.
Date Display: 2021-02-20
Title：Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
Authors：Rappazzo, C G; Tse, L V; Kaku, C I; Wrapp, D; Sakharkar, M; Huang, D; etc.
Date Display: 2021-02-19
Authors：Rappazzo, C G; Tse, L V; Kaku, C I; Wrapp, D; Sakharkar, M; Huang, D; etc.
Date Display: 2021-02-19
Title：Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Authors：Starr, T N; Greaney, A J; Addetia, A; Hannon, W W; Choudhary, M C; etc.
Date Display: 2021-02-19
Authors：Starr, T N; Greaney, A J; Addetia, A; Hannon, W W; Choudhary, M C; etc.
Date Display: 2021-02-19
Title：SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model
Authors：Qiao, J; Li, Y S; Zeng, R; Liu, F L; Luo, R H; Huang, C; Wang, Y F; Zhang, J; etc.
Date Display: 2021-02-18
Authors：Qiao, J; Li, Y S; Zeng, R; Liu, F L; Luo, R H; Huang, C; Wang, Y F; Zhang, J; etc.
Date Display: 2021-02-18
Title：Adaptive immunity to SARS-CoV-2 and COVID-19
Authors：Sette, A; Crotty, S
Date Display: 2021-02-18
Authors：Sette, A; Crotty, S
Date Display: 2021-02-18
Title：Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Authors：Gottlieb, R L; Nirula, A; Chen, P; Boscia, J; Heller, B; Morris, J; Huhn, G; etc.
Date Display: 2021-02-16
Authors：Gottlieb, R L; Nirula, A; Chen, P; Boscia, J; Heller, B; Morris, J; Huhn, G; etc.
Date Display: 2021-02-16
Title：Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
Authors：Naydenova, K; Muir, K W; Wu, L F; Zhang, Z; Coscia, F; Peet, M J; etc.
Date Display: 2021-02-16
Authors：Naydenova, K; Muir, K W; Wu, L F; Zhang, Z; Coscia, F; Peet, M J; etc.
Date Display: 2021-02-16
Title：Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Authors：
Date Display: 2021-02-13
Authors：
Date Display: 2021-02-13
Title：Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Authors：Wouters, O J; Shadlen, K C; Salcher-Konrad, M; Pollard, A J; Larson, H J; etc.
Date Display: 2021-02-12
Authors：Wouters, O J; Shadlen, K C; Salcher-Konrad, M; Pollard, A J; Larson, H J; etc.
Date Display: 2021-02-12
Title：Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Authors：Winkler, E S; Gilchuk, P; Yu, J; Bailey, A L; Chen, R E; Chong, Z; Zost, S J; etc.
Date Display: 2021-02-12
Authors：Winkler, E S; Gilchuk, P; Yu, J; Bailey, A L; Chen, R E; Chong, Z; Zost, S J; etc.
Date Display: 2021-02-12
Title：mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Authors：Wang, Z; Schmidt, F; Weisblum, Y; Muecksch, F; Barnes, C O; Finkin, S; etc.
Date Display: 2021-02-10
Authors：Wang, Z; Schmidt, F; Weisblum, Y; Muecksch, F; Barnes, C O; Finkin, S; etc.
Date Display: 2021-02-10
Title：Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Authors：Anderson, E M; Goodwin, E C; Verma, A; Arevalo, C P; Bolton, M J; etc.
Date Display: 2021-02-09
Authors：Anderson, E M; Goodwin, E C; Verma, A; Arevalo, C P; Bolton, M J; etc.
Date Display: 2021-02-09
Title：SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
Authors：Wahl, A; Gralinski, L E; Johnson, C E; Yao, W; Kovarova, M; Dinnon, KH Rd; etc.
Date Display: 2021-02-09
Authors：Wahl, A; Gralinski, L E; Johnson, C E; Yao, W; Kovarova, M; Dinnon, KH Rd; etc.
Date Display: 2021-02-09
Title：In?vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs
Authors：Sun, L; Li, P; Ju, X; Rao, J; Huang, W; Ren, L; Zhang, S; Xiong, T; Xu, K; etc.
Date Display: 2021-02-09
Authors：Sun, L; Li, P; Ju, X; Rao, J; Huang, W; Ren, L; Zhang, S; Xiong, T; Xu, K; etc.
Date Display: 2021-02-09
Title：Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation
Authors：Lapointe, C P; Grosely, R; Johnson, A G; Wang, J; Fern¨¢ndez, I S; etc.
Date Display: 2021-02-09
Authors：Lapointe, C P; Grosely, R; Johnson, A G; Wang, J; Fern¨¢ndez, I S; etc.
Date Display: 2021-02-09
Title：Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit
Authors：Slanina, H; Madhugiri, R; Bylapudi, G; Schulthei?, K; Karl, N; Gulyaeva, A; etc.
Date Display: 2021-02-09
Authors：Slanina, H; Madhugiri, R; Bylapudi, G; Schulthei?, K; Karl, N; Gulyaeva, A; etc.
Date Display: 2021-02-09
Title：SARS-CoV-2 evolution during treatment of chronic infection
Authors：Kemp, S A; Collier, D A; Datir, R P; Ferreira, IATM; Gayed, S; Jahun, A; etc.
Date Display: 2021-02-05
Authors：Kemp, S A; Collier, D A; Datir, R P; Ferreira, IATM; Gayed, S; Jahun, A; etc.
Date Display: 2021-02-05
Title：Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
Authors：McCarthy, K R; Rennick, L J; Nambulli, S; Robinson-McCarthy, L R; etc.
Date Display: 2021-02-03
Authors：McCarthy, K R; Rennick, L J; Nambulli, S; Robinson-McCarthy, L R; etc.
Date Display: 2021-02-03
Title：Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Authors：Jan, J T; Cheng, T R; Juang, Y P; Ma, H H; Wu, Y T; Yang, W B; Cheng, C W; etc.
Date Display: 2021-02-02
Authors：Jan, J T; Cheng, T R; Juang, Y P; Ma, H H; Wu, Y T; Yang, W B; Cheng, C W; etc.
Date Display: 2021-02-02
Title：Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset
Authors：Sasisekharan, V; Pentakota, N; Jayaraman, A; Tharakaraman, K; Wogan, G N; etc.
Date Display: 2021-02-02
Authors：Sasisekharan, V; Pentakota, N; Jayaraman, A; Tharakaraman, K; Wogan, G N; etc.
Date Display: 2021-02-02
Title：Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Authors：Sokal, A; Chappert, P; Barba-Spaeth, G; Roeser, A; Fourati, S; Azzaoui, I;etc.
Date Display: 2021-02-02
Authors：Sokal, A; Chappert, P; Barba-Spaeth, G; Roeser, A; Fourati, S; Azzaoui, I;etc.
Date Display: 2021-02-02
Title：BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Authors：Vogel, A B; Kanevsky, I; Che, Y; Swanson, K A; Muik, A; Vormehr, M; etc.
Date Display: 2021-02-01
Authors：Vogel, A B; Kanevsky, I; Che, Y; Swanson, K A; Muik, A; Vormehr, M; etc.
Date Display: 2021-02-01
Title：Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Authors：Muik, A; Wallisch, A K; Sänger, B; Swanson, K A; Mühl, J; Chen, W; etc.
Date Display: 2021-01-29
Authors：Muik, A; Wallisch, A K; Sänger, B; Swanson, K A; Mühl, J; Chen, W; etc.
Date Display: 2021-01-29
Title：Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Authors：Thomson, E C; Rosen, L E; Shepherd, J G; Spreafico, R; Da, Silva Filipe A; etc.
Date Display: 2021-01-28
Authors：Thomson, E C; Rosen, L E; Shepherd, J G; Spreafico, R; Da, Silva Filipe A; etc.
Date Display: 2021-01-28
Title：De novo design of modular and tunable protein biosensors
Authors：Quijano-Rubio, A; Yeh, H W; Park, J; Lee, H; Langan, R A; Boyken, S E; etc.
Date Display: 2021-01-27
Authors：Quijano-Rubio, A; Yeh, H W; Park, J; Lee, H; Langan, R A; Boyken, S E; etc.
Date Display: 2021-01-27
Title：Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Authors：Brouwer, PJM; Brinkkemper, M; Maisonnasse, P; Dereuddre-Bosquet, N; etc.
Date Display: 2021-01-26
Authors：Brouwer, PJM; Brinkkemper, M; Maisonnasse, P; Dereuddre-Bosquet, N; etc.
Date Display: 2021-01-26
Title：Covid-19: Moderna plans booster doses to counter variants
Authors：Tanne, J H
Date Display: 2021-01-26
Authors：Tanne, J H
Date Display: 2021-01-26
Title：Drug-Resistant Bacteria Outbreak Linked to COVID-19 Patient Surge
Authors：Kuehn, B M
Date Display: 2021-01-26
Authors：Kuehn, B M
Date Display: 2021-01-26
Title：Vaccinology in the post-COVID-19 era
Authors：Rappuoli, R; De Gregorio, E; Del, Giudice G; Phogat, S; Pecetta, S; Pizza, M; Hanon, E
Date Display: 2021-01-19
Authors：Rappuoli, R; De Gregorio, E; Del, Giudice G; Phogat, S; Pecetta, S; Pizza, M; Hanon, E
Date Display: 2021-01-19
Title：In silico dynamics of COVID-19 phenotypes for optimizing clinical management
Authors：Voutouri, C; Nikmaneshi, M R; Hardin, C C; Patel, A B; Verma, A; etc.
Date Display: 2021-01-19
Authors：Voutouri, C; Nikmaneshi, M R; Hardin, C C; Patel, A B; Verma, A; etc.
Date Display: 2021-01-19
Title：Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46
Authors：Persson, B D; John, L; Rafie, K; Strebl, M; Fr?ngsmyr, L; Ballmann, M Z; etc.
Date Display: 2021-01-19
Authors：Persson, B D; John, L; Rafie, K; Strebl, M; Fr?ngsmyr, L; Ballmann, M Z; etc.
Date Display: 2021-01-19
Title：Evolution of antibody immunity to SARS-CoV-2
Authors：Gaebler, C; Wang, Z; Lorenzi, JCC; Muecksch, F; Finkin, S; Tokuyama, M; etc.
Date Display: 2021-01-18
Authors：Gaebler, C; Wang, Z; Lorenzi, JCC; Muecksch, F; Finkin, S; Tokuyama, M; etc.
Date Display: 2021-01-18
Title：Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
Authors：Sadoff, J; Le Gars, M; Shukarev, G; Heerwegh, D; Truyers, C; de Groot, A M; etc.
Date Display: 2021-01-13
Authors：Sadoff, J; Le Gars, M; Shukarev, G; Heerwegh, D; Truyers, C; de Groot, A M; etc.
Date Display: 2021-01-13
Title：Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Authors：Koenig, P A; Das, H; Liu, H; K¨¹mmerer, B M; Gohr, F N; Jenster, L M; etc.
Date Display: 2021-01-12
Authors：Koenig, P A; Das, H; Liu, H; K¨¹mmerer, B M; Gohr, F N; Jenster, L M; etc.
Date Display: 2021-01-12
Title：Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas
Authors：Jung, H; Albarrac¨ªn, D
Date Display: 2021-01-05
Authors：Jung, H; Albarrac¨ªn, D
Date Display: 2021-01-05
Title：Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
Authors：So, A D; Woo, J
Date Display: 2020-12-15
Authors：So, A D; Woo, J
Date Display: 2020-12-15
Title：COVID-19-neutralizing antibodies predict disease severity and survival
Authors：Garcia-Beltran, W F; Lam, E C; Astudillo, M G; Yang, D; Miller, T E; etc.
Date Display: 2020-12-15
Authors：Garcia-Beltran, W F; Lam, E C; Astudillo, M G; Yang, D; Miller, T E; etc.
Date Display: 2020-12-15
Title：Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
Authors：Qiao, Y; Wang, X M; Mannan, R; Pitchiaya, S; Zhang, Y; Wotring, J W; etc.
Date Display: 2020-12-11
Authors：Qiao, Y; Wang, X M; Mannan, R; Pitchiaya, S; Zhang, Y; Wotring, J W; etc.
Date Display: 2020-12-11
Title：Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses
Authors：Wang, R; Simoneau, C R; Kulsuptrakul, J; Bouhaddou, M; Travisano, K A; etc.
Date Display: 2020-12-09
Authors：Wang, R; Simoneau, C R; Kulsuptrakul, J; Bouhaddou, M; Travisano, K A; etc.
Date Display: 2020-12-09
Title：Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Authors：Voysey, M; Clemens, SAC; Madhi, S A; Weckx, L Y; Folegatti, P M; Aley, P K; etc.
Date Display: 2020-12-08
Authors：Voysey, M; Clemens, SAC; Madhi, S A; Weckx, L Y; Folegatti, P M; Aley, P K; etc.
Date Display: 2020-12-08
Title：Correlates of protection against SARS-CoV-2 in rhesus macaques
Authors：McMahan, K; Yu, J; Mercado, N B; Loos, C; Tostanoski, L H; etc.
Date Display: 2020-12-04
Authors：McMahan, K; Yu, J; Mercado, N B; Loos, C; Tostanoski, L H; etc.
Date Display: 2020-12-04
Title：A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
Authors：Sanchez-Felipe, L; Vercruysse, T; Sharma, S; Ma, J; Lemmens, V;etc.
Date Display: 2020-12-01
Authors：Sanchez-Felipe, L; Vercruysse, T; Sharma, S; Ma, J; Lemmens, V;etc.
Date Display: 2020-12-01
Title：A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine
Authors：H?rner, C; Sch¨¹rmann, C; Auste, A; Ebenig, A; Muraleedharan, S;etc.
Date Display: 2020-11-30
Authors：H?rner, C; Sch¨¹rmann, C; Auste, A; Ebenig, A; Muraleedharan, S;etc.
Date Display: 2020-11-30
Title：Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
Authors：Zang, R; Case, J B; Yutuc, E; Ma, X; Shen, S; Gomez, Castro MF; etc.
Date Display: 2020-11-25
Authors：Zang, R; Case, J B; Yutuc, E; Ma, X; Shen, S; Gomez, Castro MF; etc.
Date Display: 2020-11-25
Title：Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Authors：Rodda, L B; Netland, J; Shehata, L; Pruner, K B; Morawski, P A; etc.
Date Display: 2020-11-23
Authors：Rodda, L B; Netland, J; Shehata, L; Pruner, K B; Morawski, P A; etc.
Date Display: 2020-11-23
Title：Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Authors：Karki, R; Sharma, B R; Tuladhar, S; Williams, E P; Zalduondo, L; etc.
Date Display: 2020-11-19
Authors：Karki, R; Sharma, B R; Tuladhar, S; Williams, E P; Zalduondo, L; etc.
Date Display: 2020-11-19
Title：Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Authors：Ramasamy, M N; Minassian, A M; Ewer, K J; Flaxman, A L; etc.
Date Display: 2020-11-18
Authors：Ramasamy, M N; Minassian, A M; Ewer, K J; Flaxman, A L; etc.
Date Display: 2020-11-18
Title：Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes
Authors：Zeng, H L; Dichio, V; Rodr¨ªguez, Horta E; Thorell, K; Aurell, E
Date Display: 2020-11-17
Authors：Zeng, H L; Dichio, V; Rodr¨ªguez, Horta E; Thorell, K; Aurell, E
Date Display: 2020-11-17
Title：Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis
Authors：Yan, L; Ge, J; Zheng, L; Zhang, Y; Gao, Y; Wang, T; Huang, Y; etc.
Date Display: 2020-11-14
Authors：Yan, L; Ge, J; Zheng, L; Zhang, Y; Gao, Y; Wang, T; Huang, Y; etc.
Date Display: 2020-11-14
Title：The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses
Authors：Weston, S; Baracco, L; Keller, C; Matthews, K; McGrath, M E; etc.
Date Display: 2020-11-12
Authors：Weston, S; Baracco, L; Keller, C; Matthews, K; McGrath, M E; etc.
Date Display: 2020-11-12
Title：COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice
Authors：Zheng, J; Wong, L R; Li, K; Verma, A K; Ortiz, M; etc.
Date Display: 2020-11-09
Authors：Zheng, J; Wong, L R; Li, K; Verma, A K; Ortiz, M; etc.
Date Display: 2020-11-09
Title：Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Authors：Ng, K W; Faulkner, N; Cornish, G H; Rosa, A; Harvey, R; etc.
Date Display: 2020-11-06
Authors：Ng, K W; Faulkner, N; Cornish, G H; Rosa, A; Harvey, R; etc.
Date Display: 2020-11-06
Title：An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Authors：Schoof, M; Faust, B; Saunders, R A; Sangwan, S; etc.
Date Display: 2020-11-05
Authors：Schoof, M; Faust, B; Saunders, R A; Sangwan, S; etc.
Date Display: 2020-11-05
Title：De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Authors：Linsky, T W; Vergara, R; Codina, N; Nelson, J W; Walker, M J; etc.
Date Display: 2020-11-05
Authors：Linsky, T W; Vergara, R; Codina, N; Nelson, J W; Walker, M J; etc.
Date Display: 2020-11-05
Title：Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Authors：Xiang, Y; Nambulli, S; Xiao, Z; Liu, H; Sang, Z; etc.
Date Display: 2020-11-05
Authors：Xiang, Y; Nambulli, S; Xiao, Z; Liu, H; Sang, Z; etc.
Date Display: 2020-11-05
Title：Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
Authors：Zohar, T; Loos, C; Fischinger, S; Atyeo, C; Wang, C;etc.
Date Display: 2020-11-03
Authors：Zohar, T; Loos, C; Fischinger, S; Atyeo, C; Wang, C;etc.
Date Display: 2020-11-03
Title：Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
Authors：Li, W; Chen, C; Drelich, A; Martinez, D R; Gralinski, L E; etc.
Date Display: 2020-11-02
Authors：Li, W; Chen, C; Drelich, A; Martinez, D R; Gralinski, L E; etc.
Date Display: 2020-11-02
Title：Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Authors：Walls, A C; Fiala, B; Sch?fer, A; Wrenn, S; Pham, M N; etc.
Date Display: 2020-10-31
Authors：Walls, A C; Fiala, B; Sch?fer, A; Wrenn, S; Pham, M N; etc.
Date Display: 2020-10-31
Title：Identification of SARS-CoV-2 Inhibitors using Lung and Colonic Organoids
Authors：Han, Y; Duan, X; Yang, L; Nilsson-Payant, B E; Wang, P; etc.
Date Display: 2020-10-28
Authors：Han, Y; Duan, X; Yang, L; Nilsson-Payant, B E; Wang, P; etc.
Date Display: 2020-10-28
Title：Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Authors：Wajnberg, A; Amanat, F; Firpo, A; Altman, D R; Bailey, M J; etc.
Date Display: 2020-10-28
Authors：Wajnberg, A; Amanat, F; Firpo, A; Altman, D R; Bailey, M J; etc.
Date Display: 2020-10-28
Title：Spike mutation D614G alters SARS-CoV-2 fitness
Authors：Plante, J A; Liu, Y; Liu, J; Xia, H; Johnson, B A; etc.
Date Display: 2020-10-26
Authors：Plante, J A; Liu, Y; Liu, J; Xia, H; Johnson, B A; etc.
Date Display: 2020-10-26
Title：Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells
Authors：Daniloski, Z; Jordan, T X; Wessels, H H; Hoagland, D A;etc.
Date Display: 2020-10-24
Authors：Daniloski, Z; Jordan, T X; Wessels, H H; Hoagland, D A;etc.
Date Display: 2020-10-24
Title：SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Authors：Miorin, L; Kehrer, T; Sanchez-Aparicio, M T; Zhang, K;etc.
Date Display: 2020-10-23
Authors：Miorin, L; Kehrer, T; Sanchez-Aparicio, M T; Zhang, K;etc.
Date Display: 2020-10-23
Title：Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
Authors：Glasgow, A; Glasgow, J; Limonta, D; Solomon, P; etc.
Date Display: 2020-10-22
Authors：Glasgow, A; Glasgow, J; Limonta, D; Solomon, P; etc.
Date Display: 2020-10-22
Title：Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Authors：Bangaru, S; Ozorowski, G; Turner, H L; Antanasijevic, A; etc.
Date Display: 2020-10-20
Authors：Bangaru, S; Ozorowski, G; Turner, H L; Antanasijevic, A; etc.
Date Display: 2020-10-20
Title：Neuropilin-1 is a host factor for SARS-CoV-2 infection
Authors：Daly, J L; Simonetti, B; Klein, K; Chen, K E; etc.
Date Display: 2020-10-20
Authors：Daly, J L; Simonetti, B; Klein, K; Chen, K E; etc.
Date Display: 2020-10-20
Title：Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Authors：Cantuti-Castelvetri, L; Ojha, R; Pedro, L D; etc.
Date Display: 2020-10-20
Authors：Cantuti-Castelvetri, L; Ojha, R; Pedro, L D; etc.
Date Display: 2020-10-20
Title：Transcriptional and proteomic insights into the host response in fatal COVID-19 cases
Authors：Wu, M; Chen, Y; Xia, H; Wang, C; Tan, C Y; Cai, X; etc.
Date Display: 2020-10-20
Authors：Wu, M; Chen, Y; Xia, H; Wang, C; Tan, C Y; Cai, X; etc.
Date Display: 2020-10-20
Title：Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection
Authors：Wei, J; Alfajaro, M M; DeWeirdt, P C; Hanna, R E; etc.
Date Display: 2020-10-20
Authors：Wei, J; Alfajaro, M M; DeWeirdt, P C; Hanna, R E; etc.
Date Display: 2020-10-20
Title：SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Authors：Barnes, C O; Jette, C A; Abernathy, M E; Dam, K A; etc.
Date Display: 2020-10-12
Authors：Barnes, C O; Jette, C A; Abernathy, M E; Dam, K A; etc.
Date Display: 2020-10-12
Title：REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Authors：Baum, A; Ajithdoss, D; Copin, R; Zhou, A; Lanza, K; etc.
Date Display: 2020-10-09
Authors：Baum, A; Ajithdoss, D; Copin, R; Zhou, A; Lanza, K; etc.
Date Display: 2020-10-09
Title：Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity
Authors：Kaptein, SJF; Jacobs, S; Langendries, L; Seldeslachts, L; etc.
Date Display: 2020-10-09
Authors：Kaptein, SJF; Jacobs, S; Langendries, L; Seldeslachts, L; etc.
Date Display: 2020-10-09
Title：SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses
Authors：Banerjee, A K; Blanco, M R; Bruce, E A; Honson, D D; etc.
Date Display: 2020-10-08
Authors：Banerjee, A K; Blanco, M R; Bruce, E A; Honson, D D; etc.
Date Display: 2020-10-08
Title：Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
Authors：Rao, L; Xia, S; Xu, W; Tian, R; Yu, G; Gu, C; etc.
Date Display: 2020-10-06
Authors：Rao, L; Xia, S; Xu, W; Tian, R; Yu, G; Gu, C; etc.
Date Display: 2020-10-06
Title：COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T-cell responses
Authors：Sahin, U; Muik, A; Derhovanessian, E; Vogler, I; etc.
Date Display: 2020-09-30
Authors：Sahin, U; Muik, A; Derhovanessian, E; Vogler, I; etc.
Date Display: 2020-09-30
Title：Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity
Authors：Lang, Y; Li, W; Li, Z; Koerhuis, D; van den Burg, ACS; etc.
Date Display: 2020-09-29
Authors：Lang, Y; Li, W; Li, Z; Koerhuis, D; van den Burg, ACS; etc.
Date Display: 2020-09-29
Title：Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Authors：Shrock, E; Fujimura, E; Kula, T; Timms, R T; etc.
Date Display: 2020-09-29
Authors：Shrock, E; Fujimura, E; Kula, T; Timms, R T; etc.
Date Display: 2020-09-29
Title：Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation
Authors：Cheng, M H; Zhang, S; Porritt, R A; Noval, Rivas M; etc.
Date Display: 2020-09-28
Authors：Cheng, M H; Zhang, S; Porritt, R A; Noval, Rivas M; etc.
Date Display: 2020-09-28
Title：Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
Authors：Tortorici, M A; Beltramello, M; Lempp, F A; Pinto, D; etc.
Date Display: 2020-09-24
Authors：Tortorici, M A; Beltramello, M; Lempp, F A; Pinto, D; etc.
Date Display: 2020-09-24
Title：A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
Authors：Leist, S R; Dinnon, KH Rd; Sch?fer, A; Tse, L V; etc.
Date Display: 2020-09-23
Authors：Leist, S R; Dinnon, KH Rd; Sch?fer, A; Tse, L V; etc.
Date Display: 2020-09-23
Title：A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Authors：Kreye, J; Reincke, S M; Kornau, H C; S¨¢nchez-Sendin, etc.
Date Display: 2020-09-23
Authors：Kreye, J; Reincke, S M; Kornau, H C; S¨¢nchez-Sendin, etc.
Date Display: 2020-09-23
Title：Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
Authors：Saad-Roy, C M; Wagner, C E; Baker, R E; Morris, S E; etc.
Date Display: 2020-09-21
Authors：Saad-Roy, C M; Wagner, C E; Baker, R E; Morris, S E; etc.
Date Display: 2020-09-21
Title：Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein
Authors：Toelzer, C; Gupta, K; Yadav, SKN; Borucu, U; Davidson, A D; etc.
Date Display: 2020-09-21
Authors：Toelzer, C; Gupta, K; Yadav, SKN; Borucu, U; Davidson, A D; etc.
Date Display: 2020-09-21
Title：Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
Authors：Benton, D J; Wrobel, A G; Xu, P; Roustan, C; Martin, S R; etc.
Date Display: 2020-09-17
Authors：Benton, D J; Wrobel, A G; Xu, P; Roustan, C; Martin, S R; etc.
Date Display: 2020-09-17
Title：Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Authors：Holter, J C; Pischke, S E; de Boer, E; Lind, A; Jenum, S; etc.
Date Display: 2020-09-17
Authors：Holter, J C; Pischke, S E; de Boer, E; Lind, A; Jenum, S; etc.
Date Display: 2020-09-17
Title：Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Authors：Rydyznski, Moderbacher C; Ramirez, S I; Dan, J M; Grifoni, A; etc.
Date Display: 2020-09-16
Authors：Rydyznski, Moderbacher C; Ramirez, S I; Dan, J M; Grifoni, A; etc.
Date Display: 2020-09-16
Title：Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Authors：Piccoli, L; Park, Y J; Tortorici, M A; Czudnochowski, N; etc.
Date Display: 2020-09-16
Authors：Piccoli, L; Park, Y J; Tortorici, M A; Czudnochowski, N; etc.
Date Display: 2020-09-16
Title：Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
Authors：Yurkovetskiy, L; Wang, X; Pascal, K E; Tomkins-Tinch, C; etc.
Date Display: 2020-09-15
Authors：Yurkovetskiy, L; Wang, X; Pascal, K E; Tomkins-Tinch, C; etc.
Date Display: 2020-09-15
Title：SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Authors：Clausen, T M; Sandoval, D R; Spliid, C B; Pihl, J; etc.
Date Display: 2020-09-14
Authors：Clausen, T M; Sandoval, D R; Spliid, C B; Pihl, J; etc.
Date Display: 2020-09-14
Title：Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
Authors："Du S"; Cao, Y; Zhu, Q; Yu, P; Qi, F; Wang, G; "Du X"; etc.
Date Display: 2020-09-14
Authors："Du S"; Cao, Y; Zhu, Q; Yu, P; Qi, F; Wang, G; "Du X"; etc.
Date Display: 2020-09-14
Title：Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype
Authors：Habel, J R; Nguyen, THO; van de Sandt, C E; Juno, J A; etc.
Date Display: 2020-09-10
Authors：Habel, J R; Nguyen, THO; van de Sandt, C E; Juno, J A; etc.
Date Display: 2020-09-10
Title：De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Authors：Cao, L; Goreshnik, I; Coventry, B; Case, J B; etc.
Date Display: 2020-09-09
Authors：Cao, L; Goreshnik, I; Coventry, B; Case, J B; etc.
Date Display: 2020-09-09
Title：IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
Authors：Kang, S; Tanaka, T; Inoue, H; Ono, C; Hashimoto, S; etc.
Date Display: 2020-09-08
Authors：Kang, S; Tanaka, T; Inoue, H; Ono, C; Hashimoto, S; etc.
Date Display: 2020-09-08
Title：SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification
Authors：Rabe, B A; Cepko, C
Date Display: 2020-09-08
Authors：Rabe, B A; Cepko, C
Date Display: 2020-09-08
Title：High Potency of a Bivalent Human V(H) Domain in SARS-CoV-2 Animal Models
Authors：Li, W; Sch?fer, A; Kulkarni, S S; Liu, X; Martinez, D R; etc.
Date Display: 2020-09-04
Authors：Li, W; Sch?fer, A; Kulkarni, S S; Liu, X; Martinez, D R; etc.
Date Display: 2020-09-04
Title：Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Authors：Logunov, D Y; Dolzhikova, I V; Zubkova, O V; etc.
Date Display: 2020-09-03
Authors：Logunov, D Y; Dolzhikova, I V; Zubkova, O V; etc.
Date Display: 2020-09-03
Title：Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics
Authors：Steinman, J B; Lum, F M; Ho, P P; Kaminski, N; Steinman, L
Date Display: 2020-09-03
Authors：Steinman, J B; Lum, F M; Ho, P P; Kaminski, N; Steinman, L
Date Display: 2020-09-03
Title：Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Authors：Keech, C; Albert, G; Cho, I; Robertson, A; Reed, P; etc.
Date Display: 2020-09-02
Authors：Keech, C; Albert, G; Cho, I; Robertson, A; Reed, P; etc.
Date Display: 2020-09-02
Title：A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Authors：Dearlove, B; Lewitus, E; Bai, H; Li, Y; Reeves, D B; etc.
Date Display: 2020-08-31
Authors：Dearlove, B; Lewitus, E; Bai, H; Li, Y; Reeves, D B; etc.
Date Display: 2020-08-31
Title：A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Authors：Dinnon, KH Rd; Leist, S R; Sch?fer, A; Edwards, C E; etc.
Date Display: 2020-08-27
Authors：Dinnon, KH Rd; Leist, S R; Sch?fer, A; Edwards, C E; etc.
Date Display: 2020-08-27
Title：Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Authors：Kaneko, N; Kuo, H H; Boucau, J; Farmer, J R; etc.
Date Display: 2020-08-19
Authors：Kaneko, N; Kuo, H H; Boucau, J; Farmer, J R; etc.
Date Display: 2020-08-19
Title：In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges
Authors：Turoňová, B; Sikora, M; Schürmann, C; Hagen, WJH; Welsch, S; etc.
Date Display: 2020-08-18
Authors：Turoňová, B; Sikora, M; Schürmann, C; Hagen, WJH; Welsch, S; etc.
Date Display: 2020-08-18
Title：Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Authors：Ke, Z; Oton, J; Qu, K; Cortese, M; Zila, V; McKeane, L; etc.
Date Display: 2020-08-17
Authors：Ke, Z; Oton, J; Qu, K; Cortese, M; Zila, V; McKeane, L; etc.
Date Display: 2020-08-17
Title：Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials
Authors：Xia, S; Duan, K; Zhang, Y; Zhao, D; Zhang, H; Xie, Z; etc.
Date Display: 2020-08-13
Authors：Xia, S; Duan, K; Zhang, Y; Zhao, D; Zhang, H; Xie, Z; etc.
Date Display: 2020-08-13
Title：Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
Authors：Mulligan, M J; Lyke, K E; Kitchin, N; Absalon, J; etc.
Date Display: 2020-08-12
Authors：Mulligan, M J; Lyke, K E; Kitchin, N; Absalon, J; etc.
Date Display: 2020-08-12
Title：Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Authors：Arunachalam, P S; Wimmers, F; Mok, CKP; Perera, RAPM; etc.
Date Display: 2020-08-11
Authors：Arunachalam, P S; Wimmers, F; Mok, CKP; Perera, RAPM; etc.
Date Display: 2020-08-11
Title：Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Authors：Wang, H; Zhang, Y; Huang, B; Deng, W; Quan, Y; Wang, W; etc.
Date Display: 2020-08-06
Authors：Wang, H; Zhang, Y; Huang, B; Deng, W; Quan, Y; Wang, W; etc.
Date Display: 2020-08-06
Title：Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
Authors：Kang, Y L; Chou, Y Y; Rothlauf, P W; Liu, Z; Soh, T K; etc.
Date Display: 2020-08-06
Authors：Kang, Y L; Chou, Y Y; Rothlauf, P W; Liu, Z; Soh, T K; etc.
Date Display: 2020-08-06
Title：SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Authors：Corbett, K S; Edwards, D K; Leist, S R; Abiona, O M; etc.
Date Display: 2020-08-05
Authors：Corbett, K S; Edwards, D K; Leist, S R; Abiona, O M; etc.
Date Display: 2020-08-05
Title：Covid-19: Where are we on immunity and vaccines?
Authors：Mahase, E
Date Display: 2020-08-05
Authors：Mahase, E
Date Display: 2020-08-05
Title：Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
Authors：Chan, K K; Dorosky, D; Sharma, P; Abbasi, S A; etc.
Date Display: 2020-08-04
Authors：Chan, K K; Dorosky, D; Sharma, P; Abbasi, S A; etc.
Date Display: 2020-08-04
Title：Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Authors：Gu, H; Chen, Q; Yang, G; He, L; Fan, H; Deng, Y Q; etc.
Date Display: 2020-07-30
Authors：Gu, H; Chen, Q; Yang, G; He, L; Fan, H; Deng, Y Q; etc.
Date Display: 2020-07-30
Title：ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Authors：van Doremalen, N; Lambe, T; Spencer, A; etc.
Date Display: 2020-07-30
Authors：van Doremalen, N; Lambe, T; Spencer, A; etc.
Date Display: 2020-07-30
Title：Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Authors：Mercado, N B; Zahn, R; Wegmann, F; Loos, C; etc.
Date Display: 2020-07-30
Authors：Mercado, N B; Zahn, R; Wegmann, F; Loos, C; etc.
Date Display: 2020-07-30
Title：Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Authors：Shin, D; Mukherjee, R; Grewe, D; Bojkova, D; etc.
Date Display: 2020-07-29
Authors：Shin, D; Mukherjee, R; Grewe, D; Bojkova, D; etc.
Date Display: 2020-07-29
Title：A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Authors：Yang, J; Wang, W; Chen, Z; Lu, S; Yang, F; etc.
Date Display: 2020-07-29
Authors：Yang, J; Wang, W; Chen, Z; Lu, S; Yang, F; etc.
Date Display: 2020-07-29
Title：SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Authors：Braun, J; Loyal, L; Frentsch, M; Wendisch, D; etc.
Date Display: 2020-07-29
Authors：Braun, J; Loyal, L; Frentsch, M; Wendisch, D; etc.
Date Display: 2020-07-29
Title：Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Authors：Corbett, K S; Flynn, B; Foulds, K E; Francica, J R; etc.
Date Display: 2020-07-28
Authors：Corbett, K S; Flynn, B; Foulds, K E; Francica, J R; etc.
Date Display: 2020-07-28
Title：Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex
Authors：Chen, J; Malone, B; Llewellyn, E; Grasso, M; etc.
Date Display: 2020-07-28
Authors：Chen, J; Malone, B; Llewellyn, E; Grasso, M; etc.
Date Display: 2020-07-28
Title：Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Authors：Riva, L; Yuan, S; Yin, X; Martin-Sancho, L; etc.
Date Display: 2020-07-24
Authors：Riva, L; Yuan, S; Yin, X; Martin-Sancho, L; etc.
Date Display: 2020-07-24
Title：Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
Authors：Lv, Z; Deng, Y Q; Ye, Q; Cao, L; Sun, C Y; etc.
Date Display: 2020-07-23
Authors：Lv, Z; Deng, Y Q; Ye, Q; Cao, L; Sun, C Y; etc.
Date Display: 2020-07-23
Title：Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Authors：Hsieh, C L; Goldsmith, J A; Schaub, J M; DiVenere, A M;etc.
Date Display: 2020-07-23
Authors：Hsieh, C L; Goldsmith, J A; Schaub, J M; DiVenere, A M;etc.
Date Display: 2020-07-23
Title：A Thermostable mRNA Vaccine against COVID-19
Authors：Zhang, N N; Li, X F; Deng, Y Q; Zhao, H; Huang, Y J; etc.
Date Display: 2020-07-23
Authors：Zhang, N N; Li, X F; Deng, Y Q; Zhao, H; Huang, Y J; etc.
Date Display: 2020-07-23
Title：Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike
Authors：Liu, L; Wang, P; Nair, M S; Yu, J; Rapp, M; etc.
Date Display: 2020-07-22
Authors：Liu, L; Wang, P; Nair, M S; Yu, J; Rapp, M; etc.
Date Display: 2020-07-22
Title：Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Authors：Zhu, F C; Guan, X H; Li, Y H; Huang, J Y; etc.
Date Display: 2020-07-20
Authors：Zhu, F C; Guan, X H; Li, Y H; Huang, J Y; etc.
Date Display: 2020-07-20
Title：Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Authors：Folegatti, P M; Ewer, K J; Aley, P K; Angus, B; etc.
Date Display: 2020-07-20
Authors：Folegatti, P M; Ewer, K J; Aley, P K; Angus, B; etc.
Date Display: 2020-07-20
Title：Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
Authors：Thoms, M; Buschauer, R; Ameismeier, M; Koepke, L; etc.
Date Display: 2020-07-17
Authors：Thoms, M; Buschauer, R; Ameismeier, M; Koepke, L; etc.
Date Display: 2020-07-17
Title：The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Authors：Li, Q; Wu, J; Nie, J; Zhang, L; Hao, H; Liu, S; etc.
Date Display: 2020-07-17
Authors：Li, Q; Wu, J; Nie, J; Zhang, L; Hao, H; Liu, S; etc.
Date Display: 2020-07-17
Title：Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Authors：Mathew, D; Giles, J R; Baxter, A E; Oldridge, D A; etc.
Date Display: 2020-07-15
Authors：Mathew, D; Giles, J R; Baxter, A E; Oldridge, D A; etc.
Date Display: 2020-07-15
Title：Potently neutralizing and protective human antibodies against SARS-CoV-2
Authors：Zost, S J; Gilchuk, P; Case, J B; Binshtein, E; etc.
Date Display: 2020-07-15
Authors：Zost, S J; Gilchuk, P; Case, J B; Binshtein, E; etc.
Date Display: 2020-07-15
Title：Structural basis of a shared antibody response to SARS-CoV-2
Authors：Yuan, M; Liu, H; Wu, N C; Lee, C D; Zhu, X; Zhao, F; etc.
Date Display: 2020-07-13
Authors：Yuan, M; Liu, H; Wu, N C; Lee, C D; Zhu, X; Zhao, F; etc.
Date Display: 2020-07-13
Title：Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Authors：Kreer, C; Zehner, M; Weber, T; Ercanoglu, M S; etc.
Date Display: 2020-07-13
Authors：Kreer, C; Zehner, M; Weber, T; Ercanoglu, M S; etc.
Date Display: 2020-07-13
Title：Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library
Authors：Dawadi, S; Simmons, N; Miklossy, G; Bohren, K M; Faver, J C; etc.
Date Display: 2020-07-08
Authors：Dawadi, S; Simmons, N; Miklossy, G; Bohren, K M; Faver, J C; etc.
Date Display: 2020-07-08
Title：Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface
Authors：Shigdel, U K; Lee, S J; Sowa, M E; Bowman, B R; Robison, K; etc.
Date Display: 2020-06-30
Authors：Shigdel, U K; Lee, S J; Sowa, M E; Bowman, B R; Robison, K; etc.
Date Display: 2020-06-30
Title：A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Authors：Dai, L; Zheng, T; Xu, K; Han, Y; Xu, L; Huang, E; An, Y; etc.
Date Display: 2020-06-28
Authors：Dai, L; Zheng, T; Xu, K; Han, Y; Xu, L; Huang, E; An, Y; etc.
Date Display: 2020-06-28
Title：The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Authors：Bouhaddou, M; Memon, D; Meyer, B; White, K M; Rezelj, V V; etc.
Date Display: 2020-06-28
Authors：Bouhaddou, M; Memon, D; Meyer, B; White, K M; Rezelj, V V; etc.
Date Display: 2020-06-28
Title：Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Authors：Barnes, C O; West, AP Jr; Huey-Tubman, K E; Hoffmann, MAG; etc.
Date Display: 2020-06-24
Authors：Barnes, C O; West, AP Jr; Huey-Tubman, K E; Hoffmann, MAG; etc.
Date Display: 2020-06-24
Title：A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Authors：Chi, X; Yan, R; Zhang, J; Zhang, G; Zhang, Y; Hao, M; etc.
Date Display: 2020-06-22
Authors：Chi, X; Yan, R; Zhang, J; Zhang, G; Zhang, Y; Hao, M; etc.
Date Display: 2020-06-22
Title：Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Authors：Imai, M; Iwatsuki-Horimoto, K; Hatta, M; Loeber, S; etc.
Date Display: 2020-06-22
Authors：Imai, M; Iwatsuki-Horimoto, K; Hatta, M; Loeber, S; etc.
Date Display: 2020-06-22
Title：Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Authors：Robbiani, D F; Gaebler, C; Muecksch, F; Lorenzi, JCC; etc.
Date Display: 2020-06-18
Authors：Robbiani, D F; Gaebler, C; Muecksch, F; Lorenzi, JCC; etc.
Date Display: 2020-06-18
Title：Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Authors：Rogers, T F; Zhao, F; Huang, D; Beutler, N; Burns, A; He, W T; etc.
Date Display: 2020-06-15
Authors：Rogers, T F; Zhao, F; Huang, D; Beutler, N; Burns, A; He, W T; etc.
Date Display: 2020-06-15
Title：Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Authors：Hansen, J; Baum, A; Pascal, K E; Russo, V; Giordano, S; etc.
Date Display: 2020-06-15
Authors：Hansen, J; Baum, A; Pascal, K E; Russo, V; Giordano, S; etc.
Date Display: 2020-06-15
Title：Broad neutralization of SARS-related viruses by human monoclonal antibodies
Authors：Wec, A Z; Wrapp, D; Herbert, A S; Maurer, D P; Haslwanter, D; etc.
Date Display: 2020-06-15
Authors：Wec, A Z; Wrapp, D; Herbert, A S; Maurer, D P; Haslwanter, D; etc.
Date Display: 2020-06-15
Title：Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Authors：Brouwer, PJM; Caniels, T G; van der Straten, K; Snitselaar, J L; etc.
Date Display: 2020-06-15
Authors：Brouwer, PJM; Caniels, T G; van der Straten, K; Snitselaar, J L; etc.
Date Display: 2020-06-15
Title：A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Authors：Hassan, A O; Case, J B; Winkler, E S; Thackray, L B; etc.
Date Display: 2020-06-10
Authors：Hassan, A O; Case, J B; Winkler, E S; Thackray, L B; etc.
Date Display: 2020-06-10
Title：Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
Authors：Sun, J; Zhuang, Z; Zheng, J; Li, K; Wong, R L; Liu, D; etc.
Date Display: 2020-06-10
Authors：Sun, J; Zhuang, Z; Zheng, J; Li, K; Wong, R L; Liu, D; etc.
Date Display: 2020-06-10
Title：Rapid repurposing of drugs for COVID-19
Authors：Guy, R K; DiPaola, R S; Romanelli, F; Dutch, R E
Date Display: 2020-05-22
Authors：Guy, R K; DiPaola, R S; Romanelli, F; Dutch, R E
Date Display: 2020-05-22
Title：Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Authors：Zhu, F C; Li, Y H; Guan, X H; Hou, L H; Wang, W J; etc.
Date Display: 2020-05-22
Authors：Zhu, F C; Li, Y H; Guan, X H; Hou, L H; Wang, W J; etc.
Date Display: 2020-05-22
Title：Structure of replicating SARS-CoV-2 polymerase
Authors：Hillen, H S; Kokic, G; Farnung, L; Dienemann, C; etc.
Date Display: 2020-05-21
Authors：Hillen, H S; Kokic, G; Farnung, L; Dienemann, C; etc.
Date Display: 2020-05-21
Title：Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
Authors：Jiang, R D; Liu, M Q; Chen, Y; Shan, C; Zhou, Y W; etc.
Date Display: 2020-05-21
Authors：Jiang, R D; Liu, M Q; Chen, Y; Shan, C; Zhou, Y W; etc.
Date Display: 2020-05-21
Title：DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Authors：Yu, J; Tostanoski, L H; Peter, L; Mercado, N B; etc.
Date Display: 2020-05-20
Authors：Yu, J; Tostanoski, L H; Peter, L; Mercado, N B; etc.
Date Display: 2020-05-20
Title：Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells
Authors：Cao, Y; Su, B; Guo, X; Sun, W; Deng, Y; Bao, L; Zhu, Q; etc.
Date Display: 2020-05-18
Authors：Cao, Y; Su, B; Guo, X; Sun, W; Deng, Y; Bao, L; Zhu, Q; etc.
Date Display: 2020-05-18
Title：Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Authors：Monteil, V; Kwon, H; Prado, P; Hagelkr¨¹ys, A; Wimmer, R A; etc.
Date Display: 2020-05-14
Authors：Monteil, V; Kwon, H; Prado, P; Hagelkr¨¹ys, A; Wimmer, R A; etc.
Date Display: 2020-05-14
Title：Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Authors：Abbott, T R; Dhamdhere, G; Liu, Y; Lin, X; Goudy, L; etc.
Date Display: 2020-05-14
Authors：Abbott, T R; Dhamdhere, G; Liu, Y; Lin, X; Goudy, L; etc.
Date Display: 2020-05-14
Title：Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Authors：Bojkova, D; Klann, K; Koch, B; Widera, M; Krause, D; etc.
Date Display: 2020-05-14
Authors：Bojkova, D; Klann, K; Koch, B; Widera, M; Krause, D; etc.
Date Display: 2020-05-14
Title：A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Authors：Wu, Y; Wang, F; Shen, C; Peng, W; Li, D; Zhao, C; Li, Z; etc.
Date Display: 2020-05-13
Authors：Wu, Y; Wang, F; Shen, C; Peng, W; Li, D; Zhao, C; Li, Z; etc.
Date Display: 2020-05-13
Title：The online competition between pro- and anti-vaccination views
Authors：Johnson, N F; Vel¨¢squez, N; Restrepo, N J; Leahy, R; Gabriel, N; etc.
Date Display: 2020-05-13
Authors：Johnson, N F; Vel¨¢squez, N; Restrepo, N J; Leahy, R; Gabriel, N; etc.
Date Display: 2020-05-13
Title：Rapid COVID-19 vaccine development
Authors：Graham, B S
Date Display: 2020-05-08
Authors：Graham, B S
Date Display: 2020-05-08
Title：The Equitable Distribution of COVID-19 Therapeutics and Vaccines
Authors：Bollyky, T J; Gostin, L O; Hamburg, M A
Date Display: 2020-05-07
Authors：Bollyky, T J; Gostin, L O; Hamburg, M A
Date Display: 2020-05-07
Title：Rapid Development of an inactivated vaccine candidate for SARS-CoV-2
Authors：Gao, Q; Bao, L; Mao, H; Wang, L; Xu, K; Yang, M; Li, Y; Zhu, L; etc.
Date Display: 2020-05-06
Authors：Gao, Q; Bao, L; Mao, H; Wang, L; Xu, K; Yang, M; Li, Y; Zhu, L; etc.
Date Display: 2020-05-06
Title：Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
Authors：Yin, W; Mao, C; Luan, X; Shen, D D; Shen, Q; Su, H; Wang, X; etc.
Date Display: 2020-05-01
Authors：Yin, W; Mao, C; Luan, X; Shen, D D; Shen, Q; Su, H; Wang, X; etc.
Date Display: 2020-05-01
Title：Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Authors：Dai, W; Zhang, B; Su, H; Li, J; Zhao, Y; Xie, X; Jin, Z; etc.
Date Display: 2020-04-22
Authors：Dai, W; Zhang, B; Su, H; Li, J; Zhao, Y; Xie, X; Jin, Z; etc.
Date Display: 2020-04-22
Title：Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors
Authors：Jin, Z; "Du X"; Xu, Y; Deng, Y; Liu, M; Zhao, Y; Zhang, B; Li, X; etc.
Date Display: 2020-04-09
Authors：Jin, Z; "Du X"; Xu, Y; Deng, Y; Liu, M; Zhao, Y; Zhang, B; Li, X; etc.
Date Display: 2020-04-09
Title：Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Authors：de Wit, E; Feldmann, F; Cronin, J; Jordan, R; Okumura, A;etc.
Date Display: 2020-03-24
Authors：de Wit, E; Feldmann, F; Cronin, J; Jordan, R; Okumura, A;etc.
Date Display: 2020-03-24
Title：A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Authors：Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, etc.
Date Display:
Authors：Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, etc.
Date Display: